Significant MP calls for MARC Strains (IMPC_001)
Total number of results: 1318
Gene / Allele | Procedure | Parameter | Zygosity | Sex | Phenotype | P-value | Graph |
---|---|---|---|---|---|---|---|
Fbxo38 Fbxo38em2(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Female | homozygote | female infertility | 0.0 | ||
Bbof1 Bbof1em1(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Cyp3a41b Cyp3a41btm1b(KOMP)Wtsi |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Aars2 Aars2tm1(KOMP)Wtsi |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Fbxo43 Fbxo43em1(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Female | homozygote | female infertility | 0.0 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Gross Pathology and Tissue Collection | Lung | homozygote | small lung | 0.0 | ||
Oxsm Oxsmem2(IMPC)Marc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Kmt2c Kmt2cem2(IMPC)Marc |
Gross Pathology and Tissue Collection | Spleen | heterozygote | enlarged spleen | 0.0 | ||
Fbxo24 Fbxo24em2(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Female | homozygote | female infertility | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Thymus | homozygote | small thymus | 0.0 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Skp2 Skp2em2(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Female | homozygote | female infertility | 0.0 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Gross Pathology and Tissue Collection | Brain | homozygote | decreased brain size | 0.0 | ||
Psmd14 Psmd14tm1b(NCOM)Cmhd |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Prpf31 Prpf31tm1a(EUCOMM)Wtsi |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Spata16 Spata16em1(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Female | homozygote | female infertility | 0.0 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Gross Pathology and Tissue Collection | Lung | homozygote | small lung | 0.0 | ||
Hoxc11 Hoxc11em1(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Lung | homozygote | small lung | 0.0 | ||
Fbxl5 Fbxl5em1(IMPC)Marc |
Gross Pathology and Tissue Collection | Spleen | heterozygote | enlarged spleen | 0.0 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Gross Pathology and Tissue Collection | Lung | homozygote | small lung | 0.0 | ||
Fbxo38 Fbxo38em2(IMPC)Marc |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Lung | homozygote | small lung | 0.0 | ||
Dagla Daglatm1a(EUCOMM)Wtsi |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
Lhcgr Lhcgrtm1(KOMP)Vlcg |
Gross Pathology and Tissue Collection | Brain | homozygote | decreased brain size | 0.0 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Gross Pathology and Tissue Collection | Spleen | homozygote | small spleen | 0.0 | ||
Hnrnpm Hnrnpmem1(IMPC)Marc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Stomach | homozygote | small stomach | 0.0 | ||
Nxn Nxntm1b(EUCOMM)Wtsi |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Ctu2 Ctu2tm1(KOMP)Wtsi |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Gross Pathology and Tissue Collection | Brain | homozygote | decreased brain size | 0.0 | ||
Usp10 Usp10tm1(NCOM)Mfgc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Dagla Daglatm1a(EUCOMM)Wtsi |
Gross Pathology and Tissue Collection | Thymus | homozygote | small thymus | 0.0 | ||
Spata16 Spata16em1(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Brain | homozygote | decreased brain size | 0.0 | ||
Ufm1 Ufm1em1(IMPC)Marc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Dagla Daglatm1a(EUCOMM)Wtsi |
Gross Pathology and Tissue Collection | Brain | homozygote | decreased brain size | 0.0 | ||
Usp15 Usp15em1(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Cyp3a59 Cyp3a59em1(IMPC)Marc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Dagla Daglatm1a(EUCOMM)Wtsi |
Gross Pathology and Tissue Collection | Thymus | homozygote | small thymus | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Spleen | homozygote | small spleen | 0.0 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Gross Pathology and Tissue Collection | Spleen | heterozygote | small spleen | 0.0 | ||
Lhcgr Lhcgrtm1(KOMP)Vlcg |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Spleen | homozygote | small spleen | 0.0 | ||
Lhcgr Lhcgrtm1(KOMP)Vlcg |
Gross Pathology and Tissue Collection | Heart | homozygote | small heart | 0.0 | ||
Lhcgr Lhcgrtm1(KOMP)Vlcg |
Gross Pathology and Tissue Collection | Spleen | homozygote | small spleen | 0.0 | ||
Carm1 Carm1tm1b(EUCOMM)Hmgu |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Jade1 Jade1tm1b(KOMP)Wtsi |
Fertility of Homozygous Knock-out Mice | Gross Findings Female | homozygote | female infertility | 0.0 | ||
Snx25 Snx25tm1b(KOMP)Wtsi |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Fbxo24 Fbxo24em2(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Usp50 Usp50tm1(KOMP)Vlcg |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Lhcgr Lhcgrtm1(KOMP)Vlcg |
Gross Pathology and Tissue Collection | Thymus | homozygote | small thymus | 0.0 | ||
Lhcgr Lhcgrtm1(KOMP)Vlcg |
Gross Pathology and Tissue Collection | Thymus | homozygote | small thymus | 0.0 | ||
Dagla Daglatm1a(EUCOMM)Wtsi |
Gross Pathology and Tissue Collection | Stomach | homozygote | small stomach | 0.0 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Gross Pathology and Tissue Collection | Heart | homozygote | small heart | 0.0 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Gross Pathology and Tissue Collection | Kidney | heterozygote | small kidney | 0.0 | ||
Lhcgr Lhcgrtm1(KOMP)Vlcg |
Gross Pathology and Tissue Collection | Stomach | homozygote | small stomach | 0.0 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Gross Pathology and Tissue Collection | Liver | heterozygote | small liver | 0.0 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
Prmt6 Prmt6em1(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Lhcgr Lhcgrtm1(KOMP)Vlcg |
Gross Pathology and Tissue Collection | Brain | homozygote | decreased brain size | 0.0 | ||
Erich2 Erich2em1(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Female | homozygote | female infertility | 0.0 | ||
Dctd Dctdem1(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Female | homozygote | female infertility | 0.0 | ||
Kdm5a Kdm5aem1(IMPC)Marc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Ezh1 Ezh1tm1b(EUCOMM)Wtsi |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Kmt2c Kmt2cem2(IMPC)Marc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Trim37 Trim37em1(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Female | homozygote | female infertility | 0.0 | ||
Ppp2r2a Ppp2r2atm1b(KOMP)Wtsi |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Lung | homozygote | small lung | 0.0 | ||
Kmt2a Kmt2aem1(IMPC)Marc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Brain | homozygote | decreased brain size | 0.0 | ||
Trim37 Trim37em1(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Gross Pathology and Tissue Collection | Lung | heterozygote | small lung | 0.0 | ||
Emc7 Emc7tm1b(KOMP)Mbp |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, incomplete penetrance | 0.0 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
Mir429 Mir429tm1Wtsi |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Dctd Dctdem1(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Fbxl5 Fbxl5em1(IMPC)Marc |
Gross Pathology and Tissue Collection | Spleen | heterozygote | enlarged spleen | 0.0 | ||
Fbxo38 Fbxo38em2(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Mir141 Mir141tm1Wtsi |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Dagla Daglatm1a(EUCOMM)Wtsi |
Gross Pathology and Tissue Collection | Lung | homozygote | small lung | 0.0 | ||
Dagla Daglatm1a(EUCOMM)Wtsi |
Gross Pathology and Tissue Collection | Heart | homozygote | small heart | 0.0 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Gross Pathology and Tissue Collection | Spleen | homozygote | small spleen | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Heart | homozygote | small heart | 0.0 | ||
Bod1 Bod1tm1b(KOMP)Wtsi |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Heart | homozygote | small heart | 0.0 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Gross Pathology and Tissue Collection | Heart | homozygote | small heart | 0.0 | ||
Dusp7 Dusp7tm1(KOMP)Wtsi |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Gross Pathology and Tissue Collection | Liver | heterozygote | small liver | 0.0 | ||
Ppp2r1b Ppp2r1btm1b(EUCOMM)Wtsi |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Gross Pathology and Tissue Collection | Heart | heterozygote | small heart | 0.0 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Gross Pathology and Tissue Collection | Spleen | heterozygote | small spleen | 0.0 | ||
Lhcgr Lhcgrtm1(KOMP)Vlcg |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
Fbxo22 Fbxo22tm1b(EUCOMM)Wtsi |
Fertility of Homozygous Knock-out Mice | Gross Findings Female | homozygote | female infertility | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Stomach | homozygote | small stomach | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Lung | homozygote | small lung | 0.0 | ||
Bend3 Bend3tm1b(KOMP)Mbp |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Heart | homozygote | small heart | 0.0 | ||
Usp32 Usp32em1(IMPC)Mhzh |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Thymus | homozygote | small thymus | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Stomach | homozygote | small stomach | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Kmt2c Kmt2cem2(IMPC)Marc |
Gross Pathology and Tissue Collection | Spleen | heterozygote | enlarged spleen | 0.0 | ||
Bap1 Bap1em2(IMPC)Marc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Ash1l Ash1ltm2b(EUCOMM)Hmgu |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Bnip1 Bnip1tm2b(KOMP)Wtsi |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Usp15 Usp15em1(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Female | homozygote | female infertility | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Spleen | homozygote | small spleen | 0.0 | ||
Jade1 Jade1tm1b(KOMP)Wtsi |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Gross Pathology and Tissue Collection | Lung | heterozygote | small lung | 0.0 | ||
Fbxw8 Fbxw8tm1b(EUCOMM)Hmgu |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, incomplete penetrance | 0.0 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Gross Pathology and Tissue Collection | Lung | homozygote | small lung | 0.0 | ||
Emc4 Emc4tm1(KOMP)Wtsi |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Fbxo15 Fbxo15em1(IMPC)Marc |
Gross Pathology and Tissue Collection | Spleen | homozygote | enlarged spleen | 0.0 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Gross Pathology and Tissue Collection | Heart | homozygote | small heart | 0.0 | ||
Lhcgr Lhcgrtm1(KOMP)Vlcg |
Gross Pathology and Tissue Collection | Lung | homozygote | small lung | 0.0 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Gross Pathology and Tissue Collection | Kidney | heterozygote | small kidney | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Brain | homozygote | decreased brain size | 0.0 | ||
Maob Maobem1(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Fbxo43 Fbxo43em1(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Dagla Daglatm1a(EUCOMM)Wtsi |
Gross Pathology and Tissue Collection | Heart | homozygote | small heart | 0.0 | ||
Hnrnph1 Hnrnph1tm1b(KOMP)Wtsi |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Uchl5 Uchl5tm1(NCOM)Mfgc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Fntb Fntbtm1b(EUCOMM)Hmgu |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Lhcgr Lhcgrtm1(KOMP)Vlcg |
Gross Pathology and Tissue Collection | Stomach | homozygote | small stomach | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Thymus | homozygote | small thymus | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Thymus | homozygote | small thymus | 0.0 | ||
Ppp1cb Ppp1cbem2(IMPC)Marc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Fertility of Homozygous Knock-out Mice | Gross Findings Female | homozygote | female infertility | 0.0 | ||
Bbof1 Bbof1em1(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Female | homozygote | female infertility | 0.0 | ||
Dagla Daglatm1a(EUCOMM)Wtsi |
Gross Pathology and Tissue Collection | Lung | homozygote | small lung | 0.0 | ||
Lhcgr Lhcgrtm1(KOMP)Vlcg |
Gross Pathology and Tissue Collection | Heart | homozygote | small heart | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Heart | homozygote | small heart | 0.0 | ||
Dagla Daglatm1a(EUCOMM)Wtsi |
Gross Pathology and Tissue Collection | Spleen | homozygote | small spleen | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Stomach | homozygote | small stomach | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Spleen | homozygote | small spleen | 0.0 | ||
Mir143 Mir143tm1Wtsi |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Tsg101 Tsg101tm1b(EUCOMM)Hmgu |
Gross Pathology and Tissue Collection | Kidney | heterozygote | abnormal kidney morphology | 0.0 | ||
Lhcgr Lhcgrtm1(KOMP)Vlcg |
Gross Pathology and Tissue Collection | Spleen | homozygote | small spleen | 0.0 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Gross Pathology and Tissue Collection | Heart | heterozygote | small heart | 0.0 | ||
Fbxo22 Fbxo22tm1b(EUCOMM)Wtsi |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Gross Pathology and Tissue Collection | Spleen | homozygote | small spleen | 0.0 | ||
Skp2 Skp2em2(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Brain | homozygote | decreased brain size | 0.0 | ||
Dagla Daglatm1a(EUCOMM)Wtsi |
Gross Pathology and Tissue Collection | Spleen | homozygote | small spleen | 0.0 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Gross Pathology and Tissue Collection | Heart | homozygote | small heart | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Gross Pathology and Tissue Collection | Brain | homozygote | decreased brain size | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
Tsg101 Tsg101tm1b(EUCOMM)Hmgu |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Mir320 Mir320tm1Wtsi |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Alg1 Alg1tm1b(KOMP)Wtsi |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Dagla Daglatm1a(EUCOMM)Wtsi |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
Fbxo15 Fbxo15em1(IMPC)Marc |
Gross Pathology and Tissue Collection | Spleen | homozygote | enlarged spleen | 0.0 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Gross Pathology and Tissue Collection | Brain | homozygote | decreased brain size | 0.0 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
Dagla Daglatm1a(EUCOMM)Wtsi |
Gross Pathology and Tissue Collection | Stomach | homozygote | small stomach | 0.0 | ||
Dagla Daglatm1a(EUCOMM)Wtsi |
Gross Pathology and Tissue Collection | Brain | homozygote | decreased brain size | 0.0 | ||
Dusp7 Dusp7tm1(KOMP)Wtsi |
Fertility of Homozygous Knock-out Mice | Gross Findings Female | homozygote | female infertility | 0.0 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
Erich2 Erich2em1(IMPC)Marc |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Lhcgr Lhcgrtm1(KOMP)Vlcg |
Gross Pathology and Tissue Collection | Lung | homozygote | small lung | 0.0 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Gross Pathology and Tissue Collection | Spleen | homozygote | small spleen | 0.0 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 0.0 | ||
Cdc42ep5 Cdc42ep5tm1(KOMP)Wtsi |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 0.0 | ||
Cdc42ep5 Cdc42ep5tm1(KOMP)Wtsi |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 0.0 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 0.0 | ||
Ces2e Ces2eem1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 0.0 | ||
Hectd4 Hectd4em1(IMPC)Marc |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 0.0 | ||
Fbxl19 Fbxl19tm1b(EUCOMM)Wtsi |
Hematology | Monocyte cell count | heterozygote | increased monocyte cell number | 0.0 | ||
Ppp1r14a Ppp1r14aem1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 0.0 | ||
Ppp1r14a Ppp1r14aem1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 0.0 | ||
Erich2 Erich2em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 0.0 | ||
Cdc42ep5 Cdc42ep5tm1(KOMP)Wtsi |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 0.0 | ||
Usp31 Usp31em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 0.0 | ||
Ppp1r14a Ppp1r14aem1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 0.0 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 0.0 | ||
Cdc42ep5 Cdc42ep5tm1(KOMP)Wtsi |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 0.0 | ||
Usp31 Usp31em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 0.0 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 1.401298464324817E-45 | ||
Brix1 Brix1tm1b(KOMP)Mbp |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 8.407790785948902E-45 | ||
Erich2 Erich2em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 3.0828566215145976E-44 | ||
Usp31 Usp31em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 8.547920632381384E-44 | ||
Usp31 Usp31em1(IMPC)Marc |
Hematology | Mean cell volume | homozygote | decreased mean corpuscular volume | 2.328397528322116E-41 | ||
Usp31 Usp31em1(IMPC)Marc |
Hematology | Mean cell hemoglobin concentration | homozygote | increased mean corpuscular hemoglobin concentration | 5.945008734898036E-41 | ||
Fbxo43 Fbxo43em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 1.5390601163525898E-40 | ||
Usp36 Usp36tm1b(EUCOMM)Hmgu |
Clinical Chemistry | Glucose | heterozygote | increased circulating glucose level | 1.6291495946240323E-40 | ||
Hectd1 Hectd1tm1b(EUCOMM)Hmgu |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 3.2095199897049178E-40 | ||
Etaa1 Etaa1em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 5.115005641493804E-40 | ||
Ces2e Ces2eem1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 1.0782586707723277E-38 | ||
Fbxo43 Fbxo43em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 1.4489222932841281E-38 | ||
Erich2 Erich2em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 1.6694234730081133E-38 | ||
Ces2e Ces2eem1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 1.705613138098461E-36 | ||
Brix1 Brix1tm1b(KOMP)Mbp |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 2.9012707613135305E-36 | ||
Usp31 Usp31em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 5.782725503204126E-36 | ||
Spata16 Spata16em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 8.011550753549347E-36 | ||
Cyld Cyldem2(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 1.9573423045466693E-35 | ||
Ube2e1 Ube2e1em1(IMPC)Marc |
Hematology | Mean cell hemoglobin concentration | homozygote | decreased mean corpuscular hemoglobin concentration | 4.879138980843084E-35 | ||
Ube2e1 Ube2e1em1(IMPC)Marc |
Hematology | Mean cell volume | homozygote | increased mean corpuscular volume | 5.747235819206833E-35 | ||
Hectd1 Hectd1tm1b(EUCOMM)Hmgu |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 1.2345666153709538E-34 | ||
Prdm2 Prdm2em1(IMPC)Marc |
Hematology | Mean cell hemoglobin concentration | homozygote | increased mean corpuscular hemoglobin concentration | 1.3490991396100223E-34 | ||
Etaa1 Etaa1em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 1.6784384250292344E-33 | ||
Ube2e1 Ube2e1em1(IMPC)Marc |
Hematology | Mean cell volume | homozygote | increased mean corpuscular volume | 5.849843596105283E-33 | ||
Prdm2 Prdm2em1(IMPC)Marc |
Hematology | Mean cell hemoglobin concentration | homozygote | increased mean corpuscular hemoglobin concentration | 9.318212779261384E-33 | ||
Hnrnpr Hnrnprem1(IMPC)Marc |
Hematology | Mean cell hemoglobin concentration | homozygote | decreased mean corpuscular hemoglobin concentration | 7.78707819619598E-32 | ||
Suv39h2 Suv39h2em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 9.90249371570554E-32 | ||
Spata16 Spata16em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 9.925705027156877E-32 | ||
Itprid1 Itprid1em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 8.896615206345323E-31 | ||
Hnrnpr Hnrnprem1(IMPC)Marc |
Hematology | Mean cell hemoglobin concentration | homozygote | decreased mean corpuscular hemoglobin concentration | 1.3097382507144425E-30 | ||
Spata16 Spata16em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 1.5142269658648434E-30 | ||
Ube2e1 Ube2e1em1(IMPC)Marc |
Hematology | Mean cell hemoglobin concentration | homozygote | decreased mean corpuscular hemoglobin concentration | 2.159653204042587E-30 | ||
Etaa1 Etaa1em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 8.71543259451071E-30 | ||
Suv39h2 Suv39h2em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 1.8648576526077783E-29 | ||
Hectd4 Hectd4em1(IMPC)Marc |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 1.972478768363414E-29 | ||
Brix1 Brix1tm1b(KOMP)Mbp |
Hematology | Eosinophil differential count | heterozygote | increased eosinophil cell number | 2.7025109397269024E-29 | ||
Erich2 Erich2em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 3.625697032625417E-29 | ||
Fbxo36 Fbxo36tm1b(KOMP)Wtsi |
Hematology | Mean cell volume | homozygote | decreased mean corpuscular volume | 4.543688230425501E-29 | ||
Hectd4 Hectd4em1(IMPC)Marc |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 5.787357492013559E-29 | ||
Suv39h2 Suv39h2em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 1.2271208289115318E-28 | ||
Spata16 Spata16em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 1.2490383931611446E-28 | ||
Otud1 Otud1em1(IMPC)Marc |
Open Field | Latency to center entry | homozygote | decreased exploration in new environment | 1.2953529157225258E-28 | ||
Hnrnpr Hnrnprem1(IMPC)Marc |
Hematology | Mean cell volume | homozygote | increased mean corpuscular volume | 2.627799482915193E-28 | ||
Otud6a Otud6atm1(KOMP)Vlcg |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 3.365046669332842E-28 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | BMC/Body weight | homozygote | decreased bone mineral content | 4.759763486823031E-28 | ||
Suv39h2 Suv39h2em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 4.85100393645589E-28 | ||
Ces2e Ces2eem1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 8.902069981615625E-28 | ||
Spata16 Spata16em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 3.948374016077549E-27 | ||
Usp15 Usp15em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 1.1036194108549088E-26 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 1.1067052128490038E-26 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | Neutrophil cell count | homozygote | increased neutrophil cell number | 1.1938553917252728E-26 | ||
Etaa1 Etaa1em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 4.478187405979965E-26 | ||
Hnrnph1 Hnrnph1tm1b(KOMP)Wtsi |
Hematology | Mean cell volume | heterozygote | increased mean corpuscular volume | 6.162071713486062E-26 | ||
Fbxo36 Fbxo36tm1b(KOMP)Wtsi |
Hematology | Mean cell volume | homozygote | decreased mean corpuscular volume | 7.422676370409896E-26 | ||
Hnrnpr Hnrnprem1(IMPC)Marc |
Hematology | Mean cell volume | homozygote | increased mean corpuscular volume | 8.996458806706472E-26 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | homozygote | increased fasting circulating glucose level | 1.6258817687057664E-25 | ||
Usp46 Usp46em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 5.535632215009882E-25 | ||
Usp46 Usp46em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 6.639356103712414E-25 | ||
Hnrnpd Hnrnpdtm1b(KOMP)Wtsi |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 8.45940809562928E-25 | ||
Fbxl19 Fbxl19tm1b(EUCOMM)Wtsi |
Hematology | Monocyte differential count | heterozygote | increased monocyte cell number | 3.2709314769018192E-24 | ||
Fbxo43 Fbxo43em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 6.684929584283163E-24 | ||
Hectd4 Hectd4em1(IMPC)Marc |
Hematology | Eosinophil differential count | heterozygote | increased eosinophil cell number | 1.681836303801817E-23 | ||
Emc4 Emc4tm1(KOMP)Wtsi |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 4.311587750612013E-23 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | Fat/Body weight | homozygote | increased total body fat amount | 6.029548519618797E-23 | ||
Atg4a Atg4aem2(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 1.1112476574746863E-22 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | Lean/Body weight | homozygote | decreased lean body mass | 1.8221649400742826E-22 | ||
Hnrnph1 Hnrnph1tm1b(KOMP)Wtsi |
Hematology | Mean cell volume | heterozygote | increased mean corpuscular volume | 2.864851497207635E-22 | ||
Fbxo43 Fbxo43em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 3.3146294406704056E-22 | ||
Usp32 Usp32em1(IMPC)Mhzh |
Hematology | Mean cell volume | heterozygote | increased mean corpuscular volume | 4.707619969513352E-22 | ||
Otud1 Otud1em1(IMPC)Marc |
Open Field | Latency to center entry | homozygote | decreased exploration in new environment | 5.191249512140967E-22 | ||
Usp36 Usp36tm1b(EUCOMM)Hmgu |
Clinical Chemistry | Glucose | heterozygote | increased circulating glucose level | 1.1970211221663166E-21 | ||
Itprid1 Itprid1em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 1.2280153535364798E-21 | ||
Fbxw8 Fbxw8tm1b(EUCOMM)Hmgu |
Hematology | Eosinophil differential count | heterozygote | increased eosinophil cell number | 1.3952950629152486E-21 | ||
Suv39h2 Suv39h2em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 1.4499793552490506E-21 | ||
Spata16 Spata16em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 2.163366491923134E-21 | ||
Fbxo15 Fbxo15em1(IMPC)Marc |
Hematology | Neutrophil cell count | homozygote | increased neutrophil cell number | 3.2332181874580303E-21 | ||
Usp26 Usp26em1(IMPC)Marc |
Hematology | Eosinophil cell count | hemizygote | increased eosinophil cell number | 4.0818818679756035E-21 | ||
Ezh1 Ezh1tm1b(EUCOMM)Wtsi |
Clinical Chemistry | Glucose | homozygote | increased circulating glucose level | 7.185191299842502E-21 | ||
Usp26 Usp26em1(IMPC)Marc |
Hematology | Basophil cell count | hemizygote | increased basophil cell number | 7.842554317577808E-21 | ||
Hectd1 Hectd1tm1b(EUCOMM)Hmgu |
Hematology | Eosinophil cell count | heterozygote | increased eosinophil cell number | 8.377235302920275E-21 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | homozygote | decreased bone mineral density | 1.0851001319703933E-20 | ||
Atg4a Atg4aem2(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 1.31784395708031E-20 | ||
Ash1l Ash1ltm2b(EUCOMM)Hmgu |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 1.3411166513027468E-20 | ||
Hectd1 Hectd1tm1b(EUCOMM)Hmgu |
Hematology | Eosinophil differential count | heterozygote | increased eosinophil cell number | 1.5345347429723727E-20 | ||
Fbxo43 Fbxo43em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 3.607230930649758E-20 | ||
Usp45 Usp45em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 4.1849425946273153E-20 | ||
Usp26 Usp26em1(IMPC)Marc |
Hematology | Eosinophil differential count | hemizygote | increased eosinophil cell number | 4.537725432358378E-20 | ||
Suv39h2 Suv39h2em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 6.559354849437978E-20 | ||
Hnrnpdl Hnrnpdlem1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 7.982528786858265E-20 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | homozygote | decreased bone mineral density | 1.7368666750945378E-19 | ||
Trim37 Trim37em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | BMC/Body weight | homozygote | decreased bone mineral content | 2.001924423924938E-19 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | decreased bone mineral content | 2.619721066516359E-19 | ||
Fbxw8 Fbxw8tm1b(EUCOMM)Hmgu |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 2.924010828577413E-19 | ||
Adarb1 Adarb1em1(IMPC)Marc |
Hematology | Mean cell volume | heterozygote | increased mean corpuscular volume | 5.006390199300497E-19 | ||
Hnrnpr Hnrnprem1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 5.975094693818871E-19 | ||
Hnrnpd Hnrnpdtm1b(KOMP)Wtsi |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 7.409117751207645E-19 | ||
Bap1 Bap1em2(IMPC)Marc |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 8.853487804083691E-19 | ||
Hnrnph1 Hnrnph1tm1b(KOMP)Wtsi |
Hematology | Mean cell hemoglobin concentration | heterozygote | decreased mean corpuscular hemoglobin concentration | 1.0753696413022398E-18 | ||
Pfkfb2 Pfkfb2tm1b(KOMP)Wtsi |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 1.0856456026544095E-18 | ||
Prmt6 Prmt6em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 1.3209791073112053E-18 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | Mean cell volume | homozygote | decreased mean corpuscular volume | 2.763345108358189E-18 | ||
Usp15 Usp15em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 3.474442295672822E-18 | ||
Atg4c Atg4cem2(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 3.485102172226793E-18 | ||
Fbxl2 Fbxl2em2(IMPC)Marc |
Hematology | Mean cell volume | homozygote | increased mean corpuscular volume | 4.525833935571104E-18 | ||
Hectd4 Hectd4em1(IMPC)Marc |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 4.6519587130604334E-18 | ||
Atg4c Atg4cem2(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 5.294855065665222E-18 | ||
Ash1l Ash1ltm2b(EUCOMM)Hmgu |
Hematology | Eosinophil cell count | heterozygote | increased eosinophil cell number | 6.4611007336164925E-18 | ||
Usp31 Usp31em1(IMPC)Marc |
Clinical Chemistry | Phosphorus | homozygote | increased circulating phosphate level | 7.532742582090685E-18 | ||
Fbxw8 Fbxw8tm1b(EUCOMM)Hmgu |
Hematology | Eosinophil cell count | heterozygote | increased eosinophil cell number | 8.628420231214138E-18 | ||
Fbxo38 Fbxo38em2(IMPC)Marc |
Hematology | Red blood cell distribution width | homozygote | increased red blood cell distribution width | 8.889239377338846E-18 | ||
Ppp2r5e Ppp2r5eem1(IMPC)Marc |
Hematology | Mean cell volume | homozygote | increased mean corpuscular volume | 1.0829264118267639E-17 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | Fat mass | homozygote | increased total body fat amount | 1.329577194829357E-17 | ||
Hnrnpr Hnrnprem1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 1.9516800466319104E-17 | ||
Fbxo28 Fbxo28em1(IMPC)Mhzh |
Hematology | Eosinophil cell count | heterozygote | increased eosinophil cell number | 4.336015589170702E-17 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 4.666703207479191E-17 | ||
Fbxo43 Fbxo43em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 4.929515693444029E-17 | ||
Usp15 Usp15em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 5.716033761445175E-17 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 7.102931760310374E-17 | ||
Ppp2r5e Ppp2r5eem1(IMPC)Marc |
Hematology | Mean cell volume | homozygote | increased mean corpuscular volume | 8.475198588500736E-17 | ||
AW112010 AW112010em1(IMPC)Marc |
Hematology | Mean cell volume | homozygote | decreased mean corpuscular volume | 9.70198353753323E-17 | ||
Itprid1 Itprid1em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 9.729788717515833E-17 | ||
Ube2z Ube2zem1(IMPC)Marc |
Hematology | Eosinophil differential count | heterozygote | increased eosinophil cell number | 1.1363142863785492E-16 | ||
Itprid1 Itprid1em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 1.166729386629879E-16 | ||
Etaa1 Etaa1em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 1.327245571205917E-16 | ||
Erich2 Erich2em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 1.3592479317910627E-16 | ||
Ces2e Ces2eem1(IMPC)Marc |
Hematology | Mean cell volume | homozygote | decreased mean corpuscular volume | 1.3751996797702293E-16 | ||
Usp26 Usp26em1(IMPC)Marc |
Hematology | Basophil differential count | hemizygote | increased basophil cell number | 1.664402668346857E-16 | ||
Bbc3 Bbc3em1(IMPC)Marc |
Hematology | Mean cell hemoglobin concentration | homozygote | increased mean corpuscular hemoglobin concentration | 1.7049396799689778E-16 | ||
Fbxo28 Fbxo28em1(IMPC)Mhzh |
Hematology | Eosinophil differential count | heterozygote | increased eosinophil cell number | 2.0088634394243953E-16 | ||
Adarb1 Adarb1em1(IMPC)Marc |
Hematology | Mean cell hemoglobin concentration | heterozygote | decreased mean corpuscular hemoglobin concentration | 2.3631036029246784E-16 | ||
Brix1 Brix1tm1b(KOMP)Mbp |
Hematology | Eosinophil cell count | heterozygote | increased eosinophil cell number | 2.410440568577577E-16 | ||
Prdm2 Prdm2em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 2.9503301047346074E-16 | ||
Atg4c Atg4cem2(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 3.4260690712357414E-16 | ||
Atp13a5 Atp13a5em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 3.7099860448259103E-16 | ||
Fbxo28 Fbxo28em1(IMPC)Mhzh |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 3.7772341080907974E-16 | ||
Usp45 Usp45em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 3.895064596685547E-16 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | homozygote | increased fasting circulating glucose level | 4.06333192682235E-16 | ||
Ash1l Ash1ltm2b(EUCOMM)Hmgu |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 4.611636470612556E-16 | ||
Hnrnph1 Hnrnph1tm1b(KOMP)Wtsi |
Hematology | Mean cell hemoglobin concentration | heterozygote | decreased mean corpuscular hemoglobin concentration | 5.590449745009496E-16 | ||
Prmt6 Prmt6em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 7.913284078132725E-16 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Body Composition (DEXA lean/fat) | BMC/Body weight | homozygote | decreased bone mineral content | 8.118601688173615E-16 | ||
Prdm2 Prdm2em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 1.2893917746722408E-15 | ||
Atg4a Atg4aem2(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 1.9685145220561242E-15 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Hematology | Eosinophil differential count | heterozygote | increased eosinophil cell number | 2.01812714760094E-15 | ||
Hnrnpdl Hnrnpdlem1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 2.0444146033607403E-15 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | Lean/Body weight | homozygote | decreased lean body mass | 2.3979341800509264E-15 | ||
Phf5a Phf5aem2(IMPC)Marc |
Hematology | Mean cell volume | heterozygote | increased mean corpuscular volume | 2.741370041262287E-15 | ||
Rbm11 Rbm11em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 2.911435198829637E-15 | ||
Fbxw8 Fbxw8tm1b(EUCOMM)Hmgu |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 3.597966414007562E-15 | ||
Rbm11 Rbm11em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 4.653293233321167E-15 | ||
Phf5a Phf5aem2(IMPC)Marc |
Hematology | Mean platelet volume | heterozygote | increased mean platelet volume | 4.999748343473016E-15 | ||
Emc4 Emc4tm1(KOMP)Wtsi |
Hematology | Eosinophil differential count | heterozygote | increased eosinophil cell number | 5.658150865022046E-15 | ||
Spata16 Spata16em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 6.305617344189076E-15 | ||
Atg4c Atg4cem2(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 9.508193013583067E-15 | ||
Fbxo38 Fbxo38em2(IMPC)Marc |
Hematology | Red blood cell distribution width | homozygote | increased red blood cell distribution width | 1.3174936808841783E-14 | ||
Suv39h2 Suv39h2em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 1.339974104710897E-14 | ||
Brcc3 Brcc3em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 1.4196690630258017E-14 | ||
Spata16 Spata16em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 1.4497726139712196E-14 | ||
Phf5a Phf5aem2(IMPC)Marc |
Body Composition (DEXA lean/fat) | BMC/Body weight | heterozygote | increased bone mineral content | 1.4585199232175147E-14 | ||
Ctsm Ctsmtm1(KOMP)Wtsi |
Hematology | Mean cell volume | homozygote | decreased mean corpuscular volume | 1.5481910661785912E-14 | ||
Ube2e1 Ube2e1em1(IMPC)Marc |
Hematology | Hematocrit | homozygote | increased hematocrit | 1.5862279277079928E-14 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | Lean mass | homozygote | decreased lean body mass | 1.713320478058996E-14 | ||
Rbm11 Rbm11em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 1.7734388108969594E-14 | ||
Prdm2 Prdm2em1(IMPC)Marc |
Hematology | Mean corpuscular hemoglobin | homozygote | increased mean corpuscular hemoglobin | 1.7740205531251337E-14 | ||
Prmt6 Prmt6em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 1.7749856624652352E-14 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | Monocyte cell count | homozygote | increased monocyte cell number | 2.016808317302065E-14 | ||
Adarb1 Adarb1em1(IMPC)Marc |
Hematology | Mean cell volume | heterozygote | increased mean corpuscular volume | 2.4023634847387086E-14 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | Red blood cell distribution width | homozygote | increased red blood cell distribution width | 2.53143097710953E-14 | ||
Aars2 Aars2tm1(KOMP)Wtsi |
Hematology | Eosinophil cell count | heterozygote | increased eosinophil cell number | 2.535852319687608E-14 | ||
Otud6a Otud6atm1(KOMP)Vlcg |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 2.925550155862683E-14 | ||
Prdm2 Prdm2em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 3.057097760703065E-14 | ||
Ube2e1 Ube2e1em1(IMPC)Marc |
Hematology | Hematocrit | homozygote | increased hematocrit | 3.065170662316756E-14 | ||
Atg4a Atg4aem2(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 3.6909121863427236E-14 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Combined SHIRPA and Dysmorphology | Genitalia - size | homozygote | abnormal male genitalia morphology | 6.671726837442424E-14 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Combined SHIRPA and Dysmorphology | Genitalia - presence | homozygote | absent external male genitalia | 6.671726837442424E-14 | ||
Fbxo36 Fbxo36tm1b(KOMP)Wtsi |
Hematology | Mean cell hemoglobin concentration | homozygote | increased mean corpuscular hemoglobin concentration | 7.556420224784366E-14 | ||
Ash1l Ash1ltm2b(EUCOMM)Hmgu |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 8.666847892569579E-14 | ||
Hnrnpr Hnrnprem1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 8.985728014530153E-14 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 9.69976391416473E-14 | ||
Ufc1 Ufc1em1(IMPC)Marc |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 1.0708081421345259E-13 | ||
Ctsm Ctsmtm1(KOMP)Wtsi |
Hematology | Mean cell volume | homozygote | decreased mean corpuscular volume | 1.0743963769870024E-13 | ||
Trim37 Trim37em1(IMPC)Marc |
Intraperitoneal glucose tolerance test (IPGTT) | Area under glucose response curve | homozygote | improved glucose tolerance | 1.0865806410013945E-13 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | Neutrophil differential count | homozygote | increased neutrophil cell number | 1.162917147561754E-13 | ||
Trim37 Trim37em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | homozygote | decreased bone mineral density | 1.2822459294434957E-13 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Combined SHIRPA and Dysmorphology | Genitalia - morphology | homozygote | abnormal male genitalia morphology | 1.3745441959124582E-13 | ||
Fbxo15 Fbxo15em1(IMPC)Marc |
Hematology | Lymphocyte differential count | homozygote | decreased lymphocyte cell number | 1.411058905354326E-13 | ||
Phf5a Phf5aem2(IMPC)Marc |
Hematology | Mean cell volume | heterozygote | increased mean corpuscular volume | 1.562074308878586E-13 | ||
Psmd14 Psmd14tm1b(NCOM)Cmhd |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 1.6311313465276062E-13 | ||
Ufm1 Ufm1em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Fat mass | heterozygote | increased total body fat amount | 1.7501424571728097E-13 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | Fat/Body weight | homozygote | increased total body fat amount | 1.8057000935722128E-13 | ||
Aars2 Aars2tm1(KOMP)Wtsi |
Hematology | Eosinophil differential count | heterozygote | increased eosinophil cell number | 2.050715825450966E-13 | ||
Fbxl2 Fbxl2em2(IMPC)Marc |
Hematology | Mean cell hemoglobin concentration | homozygote | decreased mean corpuscular hemoglobin concentration | 2.392306188217508E-13 | ||
Fbxo15 Fbxo15em1(IMPC)Marc |
Hematology | Neutrophil differential count | homozygote | increased neutrophil cell number | 3.5841259972933803E-13 | ||
Cimip2b Cimip2btm1(KOMP)Wtsi |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 3.6635397406697967E-13 | ||
Usp47 Usp47tm1b(EUCOMM)Wtsi |
Clinical Chemistry | HDL-cholesterol | homozygote | increased circulating HDL cholesterol level | 3.821924330835169E-13 | ||
Ube2z Ube2zem1(IMPC)Marc |
Hematology | Eosinophil differential count | heterozygote | increased eosinophil cell number | 3.839037106875137E-13 | ||
Ezh1 Ezh1tm1b(EUCOMM)Wtsi |
Clinical Chemistry | Glucose | homozygote | increased circulating glucose level | 4.335936449294253E-13 | ||
Fbxo10 Fbxo10tm1b(KOMP)Wtsi |
Hematology | Mean corpuscular hemoglobin | homozygote | decreased mean corpuscular hemoglobin | 5.201075572829061E-13 | ||
Brcc3 Brcc3em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 5.218828841302425E-13 | ||
Rbm11 Rbm11em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 5.546127793132349E-13 | ||
Ube2w Ube2wtm1b(EUCOMM)Wtsi |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | homozygote | increased fasting circulating glucose level | 6.787734979120386E-13 | ||
Fbxo10 Fbxo10tm1b(KOMP)Wtsi |
Clinical Chemistry | Triglycerides | homozygote | decreased circulating triglyceride level | 6.865202850647734E-13 | ||
Brcc3 Brcc3em1(IMPC)Marc |
Hematology | Mean cell volume | homozygote | increased mean corpuscular volume | 7.19683427435891E-13 | ||
Hnrnpdl Hnrnpdlem1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 7.767296463130624E-13 | ||
Usp31 Usp31em1(IMPC)Marc |
Hematology | Hematocrit | homozygote | decreased hematocrit | 8.996123616010487E-13 | ||
Pfkfb2 Pfkfb2tm1b(KOMP)Wtsi |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 1.1277167350984274E-12 | ||
Prmt6 Prmt6em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 1.1605593873073583E-12 | ||
Cyld Cyldem2(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 1.3487884854140875E-12 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | decreased bone mineral content | 1.3566803930276095E-12 | ||
Gsdma3 Gsdma3tm1(KOMP)Vlcg |
Hematology | Mean corpuscular hemoglobin | homozygote | increased mean corpuscular hemoglobin | 1.367690574509417E-12 | ||
Etaa1 Etaa1em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 1.4979156153296924E-12 | ||
Adarb1 Adarb1em1(IMPC)Marc |
Hematology | Mean cell hemoglobin concentration | heterozygote | decreased mean corpuscular hemoglobin concentration | 1.5250929859267348E-12 | ||
Fbxo10 Fbxo10tm1b(KOMP)Wtsi |
Hematology | Mean cell volume | homozygote | decreased mean corpuscular volume | 1.7588839456086913E-12 | ||
Gsdma3 Gsdma3tm1(KOMP)Vlcg |
Hematology | Mean cell hemoglobin concentration | homozygote | increased mean corpuscular hemoglobin concentration | 1.911127289408454E-12 | ||
Fbxo15 Fbxo15em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 2.0338594090146822E-12 | ||
Usp47 Usp47tm1b(EUCOMM)Wtsi |
Clinical Chemistry | Total cholesterol | homozygote | increased circulating cholesterol level | 2.108181684778998E-12 | ||
Usp46 Usp46em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 2.1634380484997218E-12 | ||
Hectd4 Hectd4em1(IMPC)Marc |
Hematology | Eosinophil cell count | heterozygote | increased eosinophil cell number | 2.19517589869489E-12 | ||
Hnrnpr Hnrnprem1(IMPC)Marc |
Hematology | Lymphocyte cell count | homozygote | increased lymphocyte cell number | 2.2055844563911853E-12 | ||
Cyld Cyldem2(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 2.6170903551919755E-12 | ||
Trim37 Trim37em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Fat/Body weight | homozygote | increased total body fat amount | 2.7133308620752583E-12 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | Mean cell volume | homozygote | decreased mean corpuscular volume | 3.4115061036538163E-12 | ||
Eddm3b Eddm3btm1b(KOMP)Wtsi |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 4.013622333792766E-12 | ||
Rbm11 Rbm11em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 4.4550847386193304E-12 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | Lean mass | homozygote | decreased lean body mass | 5.349229739715078E-12 | ||
Usp46 Usp46em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 6.415296245620983E-12 | ||
Etaa1 Etaa1em1(IMPC)Marc |
Hematology | Red blood cell distribution width | homozygote | increased red blood cell distribution width | 8.146300474465296E-12 | ||
Cpa1 Cpa1em1(IMPC)Marc |
Hematology | Lymphocyte cell count | homozygote | increased lymphocyte cell number | 9.415334831230915E-12 | ||
Otud6a Otud6atm1(KOMP)Vlcg |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 1.045046427866625E-11 | ||
Fbxo36 Fbxo36tm1b(KOMP)Wtsi |
Hematology | Mean cell hemoglobin concentration | homozygote | increased mean corpuscular hemoglobin concentration | 1.0580396801740388E-11 | ||
Lhcgr Lhcgrtm1(KOMP)Vlcg |
Hematology | White blood cell count | homozygote | increased leukocyte cell number | 1.0758796631371581E-11 | ||
Fbxo10 Fbxo10tm1b(KOMP)Wtsi |
Clinical Chemistry | Urea (Blood Urea Nitrogen - BUN) | homozygote | decreased blood urea nitrogen level | 1.204197418863684E-11 | ||
Esr2 Esr2em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Fat/Body weight | homozygote | increased total body fat amount | 1.327294784497779E-11 | ||
Fancl Fancltm1b(EUCOMM)Hmgu |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 1.3856750816221286E-11 | ||
Cyld Cyldem2(IMPC)Marc |
Open Field | Periphery resting time | homozygote | decreased locomotor activity | 1.4298748816921059E-11 | ||
Ankle1 Ankle1tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Coat - color - head | homozygote | abnormal coat/hair pigmentation | 1.6593728127678453E-11 | ||
Cox8a Cox8aem1(IMPC)Marc |
Clinical Chemistry | Triglycerides | homozygote | increased circulating triglyceride level | 1.688901102303575E-11 | ||
Cyld Cyldem2(IMPC)Marc |
Open Field | Periphery average speed | homozygote | decreased locomotor activity | 1.7281925890344496E-11 | ||
Phf5a Phf5aem2(IMPC)Marc |
Body Composition (DEXA lean/fat) | BMC/Body weight | heterozygote | increased bone mineral content | 1.7606459692953713E-11 | ||
Rbm11 Rbm11em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 1.7739870336597185E-11 | ||
Dlgap2 Dlgap2em1(IMPC)Mhzh |
Hematology | Neutrophil differential count | homozygote | increased neutrophil cell number | 1.8359227332842565E-11 | ||
Zdhhc2 Zdhhc2tm1b(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Lower lip morphology | homozygote | abnormal lip morphology | 1.9377477053494907E-11 | ||
Fshr Fshrtm1(KOMP)Vlcg |
Body Composition (DEXA lean/fat) | BMC/Body weight | homozygote | decreased bone mineral content | 1.98331177869715E-11 | ||
Ankle1 Ankle1tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Coat - color - abdomen | homozygote | abnormal coat/hair pigmentation | 2.342643960762114E-11 | ||
Fbxo36 Fbxo36tm1b(KOMP)Wtsi |
Hematology | Mean platelet volume | homozygote | decreased mean platelet volume | 2.7548964845469648E-11 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Hematology | Eosinophil differential count | heterozygote | increased eosinophil cell number | 2.7630477766882322E-11 | ||
Usp31 Usp31em1(IMPC)Marc |
Acoustic Startle and Pre-pulse Inhibition (PPI) | % Pre-pulse inhibition - PPI1 | homozygote | increased prepulse inhibition | 2.843287584541887E-11 | ||
Fbxo43 Fbxo43em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 2.9192842587733026E-11 | ||
Esr2 Esr2em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Lean/Body weight | homozygote | decreased lean body mass | 3.3062021870255975E-11 | ||
Ash1l Ash1ltm2b(EUCOMM)Hmgu |
Eye Morphology | Pupil Light Response | heterozygote | impaired pupillary reflex | 3.512077087486354E-11 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | Lymphocyte differential count | homozygote | decreased lymphocyte cell number | 3.702719381104558E-11 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | homozygote | decreased bone mineral density | 3.776940912803006E-11 | ||
Fbxo2 Fbxo2tm1b(EUCOMM)Wtsi |
Clinical Chemistry | Glucose | homozygote | increased circulating glucose level | 3.8915305006215206E-11 | ||
Rbm11 Rbm11em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 4.1465088307379716E-11 | ||
Atg4b Atg4bem1(IMPC)Marc |
Clinical Chemistry | Urea (Blood Urea Nitrogen - BUN) | homozygote | decreased blood urea nitrogen level | 4.202541786790803E-11 | ||
Dlgap2 Dlgap2em1(IMPC)Mhzh |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 4.46609901838535E-11 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Grip Strength | Forelimb and hindlimb grip strength measurement mean | homozygote | decreased grip strength | 4.6738442976979044E-11 | ||
Ufc1 Ufc1em1(IMPC)Marc |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 4.780797979719864E-11 | ||
Fancl Fancltm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | decreased bone mineral content | 4.9669799523366365E-11 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | Bone Area | homozygote | abnormal bone structure | 5.219737836403837E-11 | ||
Vav2 Vav2em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 5.66362338971782E-11 | ||
Atg4c Atg4cem2(IMPC)Marc |
Hematology | Neutrophil cell count | homozygote | increased neutrophil cell number | 6.261693247244793E-11 | ||
Dlgap2 Dlgap2em1(IMPC)Mhzh |
Hematology | Lymphocyte differential count | homozygote | decreased lymphocyte cell number | 6.541472225007894E-11 | ||
Usp15 Usp15em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 6.607826785742787E-11 | ||
Dlgap2 Dlgap2em1(IMPC)Mhzh |
Hematology | Neutrophil cell count | homozygote | increased neutrophil cell number | 6.677599445614746E-11 | ||
Ufm1 Ufm1em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Fat/Body weight | heterozygote | increased total body fat amount | 7.345675456793543E-11 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Open Field | Periphery resting time | homozygote | decreased locomotor activity | 7.495190579298594E-11 | ||
Bap1 Bap1em2(IMPC)Marc |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 8.351216246316184E-11 | ||
Hectd4 Hectd4em1(IMPC)Marc |
Hematology | Eosinophil differential count | heterozygote | increased eosinophil cell number | 8.911409110634594E-11 | ||
Cyld Cyldem2(IMPC)Marc |
Open Field | Whole arena resting time | homozygote | decreased locomotor activity | 9.13792097545496E-11 | ||
Emc4 Emc4tm1(KOMP)Wtsi |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 9.939920414536729E-11 | ||
Trim37 Trim37em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | decreased bone mineral content | 9.946409668115663E-11 | ||
Prdm2 Prdm2em1(IMPC)Marc |
Hematology | Mean corpuscular hemoglobin | homozygote | increased mean corpuscular hemoglobin | 1.0705081959772045E-10 | ||
Ctsm Ctsmtm1(KOMP)Wtsi |
Hematology | Monocyte differential count | homozygote | increased monocyte cell number | 1.1216463868812809E-10 | ||
Cdc42ep5 Cdc42ep5tm1(KOMP)Wtsi |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 1.1777662178857895E-10 | ||
Ankrd65 Ankrd65tm1(KOMP)Wtsi |
Open Field | Latency to center entry | homozygote | decreased exploration in new environment | 1.2999898379995045E-10 | ||
Ppp2r2a Ppp2r2atm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Lean mass | heterozygote | decreased lean body mass | 1.329385490578261E-10 | ||
Ankle1 Ankle1tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Coat - color - back | homozygote | abnormal coat/hair pigmentation | 1.3779541396807815E-10 | ||
Hnrnpr Hnrnprem1(IMPC)Marc |
Hematology | Hematocrit | homozygote | increased hematocrit | 1.3795437014962886E-10 | ||
Bbc3 Bbc3em1(IMPC)Marc |
Hematology | Mean cell hemoglobin concentration | homozygote | increased mean corpuscular hemoglobin concentration | 1.4424290928349848E-10 | ||
Ces2e Ces2eem1(IMPC)Marc |
Hematology | Mean corpuscular hemoglobin | homozygote | decreased mean corpuscular hemoglobin | 1.4879224241592937E-10 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | Fat mass | homozygote | increased total body fat amount | 1.489402212673241E-10 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 1.5396355024233088E-10 | ||
Fancl Fancltm1b(EUCOMM)Hmgu |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 1.5781256856861603E-10 | ||
Cdc42ep5 Cdc42ep5tm1(KOMP)Wtsi |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 1.6263806967842243E-10 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Open Field | Whole arena resting time | homozygote | decreased locomotor activity | 1.8973708715286364E-10 | ||
Hectd4 Hectd4em1(IMPC)Marc |
Hematology | Eosinophil cell count | heterozygote | increased eosinophil cell number | 1.936969612481576E-10 | ||
Prdm2 Prdm2em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 1.9681571650220775E-10 | ||
Cpa1 Cpa1em1(IMPC)Marc |
Hematology | Mean corpuscular hemoglobin | homozygote | increased mean corpuscular hemoglobin | 1.971008495305071E-10 | ||
Fbxl2 Fbxl2em2(IMPC)Marc |
Hematology | Mean corpuscular hemoglobin | homozygote | increased mean corpuscular hemoglobin | 2.0295559677308006E-10 | ||
Apbb3 Apbb3em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 2.259569059637201E-10 | ||
Bbc3 Bbc3em1(IMPC)Marc |
Hematology | Mean corpuscular hemoglobin | homozygote | increased mean corpuscular hemoglobin | 2.411409405489451E-10 | ||
Fbxw13 Fbxw13em2(IMPC)Marc |
Hematology | Mean cell volume | homozygote | increased mean corpuscular volume | 2.4206611715094084E-10 | ||
Ufc1 Ufc1em1(IMPC)Marc |
Hematology | Eosinophil differential count | heterozygote | increased eosinophil cell number | 2.422804179502691E-10 | ||
Apbb3 Apbb3em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 2.8735722135131425E-10 | ||
Fancl Fancltm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | BMC/Body weight | homozygote | decreased bone mineral content | 2.9872540552311477E-10 | ||
Cyld Cyldem2(IMPC)Marc |
Open Field | Distance travelled - total | homozygote | decreased locomotor activity | 3.108718282796019E-10 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | Mean platelet volume | homozygote | increased mean platelet volume | 3.1381247600492657E-10 | ||
Bod1 Bod1tm1b(KOMP)Wtsi |
Hematology | Eosinophil cell count | heterozygote | increased eosinophil cell number | 3.155044558944553E-10 | ||
Fbxl19 Fbxl19tm1b(EUCOMM)Wtsi |
Hematology | Lymphocyte differential count | heterozygote | decreased lymphocyte cell number | 3.447233054565402E-10 | ||
Eddm3b Eddm3btm1b(KOMP)Wtsi |
Eye Morphology | Iris Pigmentation | homozygote | abnormal iris pigmentation | 3.5388308949890757E-10 | ||
Usp15 Usp15em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 3.573746021334756E-10 | ||
Ash1l Ash1ltm2b(EUCOMM)Hmgu |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 3.818070581917965E-10 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | White blood cell count | homozygote | increased leukocyte cell number | 3.9608599733398364E-10 | ||
Esr2 Esr2em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Fat mass | homozygote | increased total body fat amount | 4.200962910871908E-10 | ||
Cimip2b Cimip2btm1(KOMP)Wtsi |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 4.64419863677179E-10 | ||
AW112010 AW112010em1(IMPC)Marc |
Hematology | Mean corpuscular hemoglobin | homozygote | decreased mean corpuscular hemoglobin | 4.75263550736571E-10 | ||
Alg1 Alg1tm1b(KOMP)Wtsi |
Hematology | Eosinophil differential count | heterozygote | increased eosinophil cell number | 4.812816256638541E-10 | ||
Hnrnpr Hnrnprem1(IMPC)Marc |
Hematology | White blood cell count | homozygote | increased leukocyte cell number | 4.946920650894526E-10 | ||
Hectd1 Hectd1tm1b(EUCOMM)Hmgu |
Clinical Chemistry | Calcium | heterozygote | increased circulating calcium level | 5.151917226164926E-10 | ||
Fancl Fancltm1b(EUCOMM)Hmgu |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 5.231832744811982E-10 | ||
Fbxo43 Fbxo43em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 5.298748662063701E-10 | ||
Fbxo22 Fbxo22tm1b(EUCOMM)Wtsi |
Combined SHIRPA and Dysmorphology | Tail - morphology | homozygote | abnormal tail morphology | 5.340325959224401E-10 | ||
Zfp36 Zfp36tm1(KOMP)Vlcg |
Hematology | Mean cell volume | heterozygote | decreased mean corpuscular volume | 5.640804490170126E-10 | ||
Atp13a5 Atp13a5em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 5.780683709488699E-10 | ||
Suv39h2 Suv39h2em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 6.026235066514118E-10 | ||
Erich2 Erich2em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 6.152171549977936E-10 | ||
Ccdc83 Ccdc83em1(IMPC)Marc |
Hematology | Lymphocyte cell count | homozygote | decreased lymphocyte cell number | 6.570474164746543E-10 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Grip Strength | Forelimb and hindlimb grip strength normalised against body weight | homozygote | decreased grip strength | 7.879936148036393E-10 | ||
Ash1l Ash1ltm2b(EUCOMM)Hmgu |
Heart Weight | Heart weight | heterozygote | increased heart weight | 9.528856592666557E-10 | ||
Vav2 Vav2em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 1.0167769959323891E-9 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Open Field | Latency to center entry | homozygote | decreased exploration in new environment | 1.042132380391081E-9 | ||
Atp13a5 Atp13a5em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 1.1246419351351733E-9 | ||
Trim37 Trim37em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Lean/Body weight | homozygote | decreased lean body mass | 1.2798783144418735E-9 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Open Field | Periphery resting time | heterozygote | decreased locomotor activity | 1.2800535076351593E-9 | ||
Fbxo36 Fbxo36tm1b(KOMP)Wtsi |
Hematology | Hematocrit | homozygote | decreased hematocrit | 1.2821612660474102E-9 | ||
Cyld Cyldem2(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 1.3019286759785587E-9 | ||
Fancl Fancltm1b(EUCOMM)Hmgu |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 1.3090530881498808E-9 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Open Field | Whole arena resting time | heterozygote | decreased locomotor activity | 1.4854438790123936E-9 | ||
Rbm11 Rbm11em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 1.6899114330115594E-9 | ||
Fbxo28 Fbxo28em1(IMPC)Mhzh |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 1.7720341860538724E-9 | ||
Ufm1 Ufm1em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | BMC/Body weight | heterozygote | decreased bone mineral content | 2.4165951462151725E-9 | ||
Ufm1 Ufm1em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | heterozygote | decreased bone mineral density | 2.563832479651751E-9 | ||
B3galt1 B3galt1em1(IMPC)Marc |
Hematology | Mean platelet volume | homozygote | increased mean platelet volume | 2.5985613660850504E-9 | ||
Ufm1 Ufm1em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Lean/Body weight | heterozygote | decreased lean body mass | 2.754716676989233E-9 | ||
Hnrnpd Hnrnpdtm1b(KOMP)Wtsi |
Hematology | Lymphocyte cell count | heterozygote | decreased lymphocyte cell number | 3.2092137836059464E-9 | ||
Usp31 Usp31em1(IMPC)Marc |
Clinical Chemistry | Glucose | homozygote | increased circulating glucose level | 3.2136975303131976E-9 | ||
Dlgap2 Dlgap2em1(IMPC)Mhzh |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 3.5158256306289104E-9 | ||
Usp45 Usp45em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 3.5645739693279666E-9 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Open Field | Periphery resting time | heterozygote | decreased locomotor activity | 3.964859995875258E-9 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Open Field | Whole arena resting time | heterozygote | decreased locomotor activity | 4.015604293527986E-9 | ||
Usp15 Usp15em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 4.120611407643082E-9 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Body Composition (DEXA lean/fat) | Bone Area | homozygote | abnormal bone structure | 4.258501995479946E-9 | ||
Fbxo36 Fbxo36tm1b(KOMP)Wtsi |
Hematology | Hematocrit | homozygote | decreased hematocrit | 4.346282889144959E-9 | ||
Usp32 Usp32em1(IMPC)Mhzh |
Hematology | Platelet count | heterozygote | thrombocytosis | 4.6050030455546676E-9 | ||
Cyld Cyldem2(IMPC)Marc |
Open Field | Whole arena average speed | homozygote | decreased locomotor activity | 4.745963178010015E-9 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | White blood cell count | homozygote | increased leukocyte cell number | 4.7888470966483965E-9 | ||
Fbxo38 Fbxo38em2(IMPC)Marc |
Clinical Chemistry | Aspartate aminotransferase | homozygote | increased circulating aspartate transaminase level | 4.84226925223652E-9 | ||
Ces2f Ces2ftm1b(KOMP)Wtsi |
Hematology | Red blood cell distribution width | homozygote | increased red blood cell distribution width | 4.975945433471907E-9 | ||
Usp32 Usp32em1(IMPC)Mhzh |
Hematology | Lymphocyte cell count | heterozygote | increased lymphocyte cell number | 5.040092787567119E-9 | ||
Adarb1 Adarb1em1(IMPC)Marc |
Hematology | Hematocrit | heterozygote | increased hematocrit | 5.064535013588056E-9 | ||
Fancl Fancltm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | Bone Area | homozygote | abnormal bone structure | 5.108797385133812E-9 | ||
Ash1l Ash1ltm2b(EUCOMM)Hmgu |
Hematology | Eosinophil differential count | heterozygote | increased eosinophil cell number | 5.423667737147753E-9 | ||
Fbxo10 Fbxo10tm1b(KOMP)Wtsi |
Echo | Fractional Shortening | homozygote | decreased cardiac muscle contractility | 5.486392673503815E-9 | ||
Ppp2r2a Ppp2r2atm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Body length | heterozygote | decreased body length | 5.514311229859459E-9 | ||
Phf5a Phf5aem2(IMPC)Marc |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | heterozygote | increased fasting circulating glucose level | 5.803105995738633E-9 | ||
Fbxo15 Fbxo15em1(IMPC)Marc |
Hematology | White blood cell count | homozygote | increased leukocyte cell number | 5.941455771818482E-9 | ||
Cyld Cyldem2(IMPC)Marc |
Grip Strength | Forelimb and hindlimb grip strength normalised against body weight | homozygote | increased grip strength | 5.970625327478274E-9 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | Lymphocyte cell count | homozygote | increased lymphocyte cell number | 6.135889574210296E-9 | ||
Fancl Fancltm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | homozygote | decreased bone mineral density | 6.624129245125232E-9 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | Mean corpuscular hemoglobin | homozygote | decreased mean corpuscular hemoglobin | 6.746980751870524E-9 | ||
Dusp7 Dusp7tm1(KOMP)Wtsi |
Clinical Chemistry | HDL-cholesterol | homozygote | decreased circulating HDL cholesterol level | 7.136004231966808E-9 | ||
Fbxo36 Fbxo36tm1b(KOMP)Wtsi |
Hematology | Mean platelet volume | homozygote | decreased mean platelet volume | 7.158761139436365E-9 | ||
Hnrnpdl Hnrnpdlem1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 7.204330465526709E-9 | ||
Ints6l Ints6lem1(IMPC)Marc |
Echo | LVIDs | hemizygote | dilated heart left ventricle | 7.558722536771256E-9 | ||
Alg1 Alg1tm1b(KOMP)Wtsi |
Hematology | Eosinophil cell count | heterozygote | increased eosinophil cell number | 7.648031541407363E-9 | ||
Esr2 Esr2em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Lean mass | homozygote | decreased lean body mass | 7.894535691832516E-9 | ||
Phf5a Phf5aem2(IMPC)Marc |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | heterozygote | increased fasting circulating glucose level | 8.869127654520526E-9 | ||
Ash1l Ash1ltm2b(EUCOMM)Hmgu |
Hematology | Eosinophil differential count | heterozygote | increased eosinophil cell number | 8.980912902245564E-9 | ||
Brcc3 Brcc3em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 9.913390996985072E-9 | ||
Usp45 Usp45em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 9.95139792792088E-9 | ||
Ppp2r5e Ppp2r5eem1(IMPC)Marc |
Combined SHIRPA and Dysmorphology | Locomotor activity | homozygote | decreased exploration in new environment | 1.0062457533877023E-8 | ||
Fbxo27 Fbxo27em2(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 1.0614478185289045E-8 | ||
Cyld Cyldem2(IMPC)Marc |
Open Field | Periphery distance travelled | homozygote | decreased locomotor activity | 1.1384132747593867E-8 | ||
Ube2d3 Ube2d3tm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | heterozygote | decreased bone mineral content | 1.1579621705948284E-8 | ||
Ctu2 Ctu2tm1(KOMP)Wtsi |
Hematology | Eosinophil differential count | heterozygote | increased eosinophil cell number | 1.2052303155485333E-8 | ||
Bbof1 Bbof1em1(IMPC)Marc |
Hematology | Mean cell hemoglobin concentration | homozygote | increased mean corpuscular hemoglobin concentration | 1.2401885740587204E-8 | ||
Usp47 Usp47tm1b(EUCOMM)Wtsi |
Clinical Chemistry | Alkaline phosphatase | homozygote | increased circulating alkaline phosphatase level | 1.2974878060845185E-8 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | homozygote | decreased bone mineral density | 1.368046120830968E-8 | ||
Cox8a Cox8aem1(IMPC)Marc |
Grip Strength | Forelimb grip strength measurement mean | homozygote | decreased grip strength | 1.4696404981862088E-8 | ||
Ctsm Ctsmtm1(KOMP)Wtsi |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | homozygote | increased fasting circulating glucose level | 1.5690677201973813E-8 | ||
Usp32 Usp32em1(IMPC)Mhzh |
Hematology | Mean cell hemoglobin concentration | heterozygote | decreased mean corpuscular hemoglobin concentration | 1.615726752390856E-8 | ||
Trim37 Trim37em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Fat mass | homozygote | increased total body fat amount | 1.6499100752298546E-8 | ||
Otud3 Otud3em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Lean mass | homozygote | increased lean body mass | 1.7468568813683305E-8 | ||
Ctu2 Ctu2tm1(KOMP)Wtsi |
Hematology | Eosinophil differential count | heterozygote | increased eosinophil cell number | 1.7773221117067806E-8 | ||
Atg4a Atg4aem2(IMPC)Marc |
Body Composition (DEXA lean/fat) | BMC/Body weight | homozygote | decreased bone mineral content | 1.8028059045605005E-8 | ||
Ash1l Ash1ltm2b(EUCOMM)Hmgu |
Hematology | Eosinophil cell count | heterozygote | increased eosinophil cell number | 1.8318846883857987E-8 | ||
Ces1f Ces1ftm1b(KOMP)Wtsi |
Hematology | Mean cell volume | homozygote | increased mean corpuscular volume | 1.839845076290203E-8 | ||
Ints6l Ints6lem1(IMPC)Marc |
Echo | LVPWd | hemizygote | thin ventricular wall | 1.902434298983735E-8 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | Monocyte differential count | homozygote | decreased monocyte cell number | 1.917098479964352E-8 | ||
Ube2z Ube2zem1(IMPC)Marc |
Hematology | Eosinophil cell count | heterozygote | increased eosinophil cell number | 2.02684002914566E-8 | ||
Dlgap2 Dlgap2em1(IMPC)Mhzh |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | homozygote | increased fasting circulating glucose level | 2.096318496569438E-8 | ||
Kics2 Kics2tm1b(KOMP)Wtsi |
Clinical Chemistry | HDL-cholesterol | homozygote | decreased circulating HDL cholesterol level | 2.0969784131352753E-8 | ||
Ufm1 Ufm1em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | heterozygote | decreased bone mineral content | 2.0979562975753652E-8 | ||
Atp13a5 Atp13a5em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 2.1104753500367224E-8 | ||
Cpa1 Cpa1em1(IMPC)Marc |
Hematology | Mean corpuscular hemoglobin | homozygote | increased mean corpuscular hemoglobin | 2.1926947368910987E-8 | ||
Prpf31 Prpf31tm1a(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | Fat/Body weight | heterozygote | increased total body fat amount | 2.279264954552218E-8 | ||
Usp32 Usp32em1(IMPC)Mhzh |
Hematology | Mean platelet volume | heterozygote | increased mean platelet volume | 2.2882559846948425E-8 | ||
Brcc3 Brcc3em1(IMPC)Marc |
Hematology | Mean cell volume | homozygote | increased mean corpuscular volume | 2.6561844279626712E-8 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | BMC/Body weight | homozygote | decreased bone mineral content | 2.7975492145060343E-8 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Open Field | Number of center entries | heterozygote | decreased locomotor activity | 2.897897033449226E-8 | ||
Atg4c Atg4cem2(IMPC)Marc |
Hematology | Lymphocyte differential count | homozygote | decreased lymphocyte cell number | 2.913873586862792E-8 | ||
Brcc3 Brcc3em1(IMPC)Marc |
Hematology | Mean corpuscular hemoglobin | homozygote | increased mean corpuscular hemoglobin | 2.9154023195587797E-8 | ||
Hnrnpd Hnrnpdtm1b(KOMP)Wtsi |
Hematology | Eosinophil differential count | heterozygote | increased eosinophil cell number | 3.1510786868693685E-8 | ||
Atg4a Atg4aem2(IMPC)Marc |
Body Composition (DEXA lean/fat) | Fat/Body weight | homozygote | increased total body fat amount | 3.2263510973962184E-8 | ||
Otud3 Otud3em1(IMPC)Marc |
Open Field | Latency to center entry | homozygote | decreased exploration in new environment | 3.252362645866924E-8 | ||
Fbxo10 Fbxo10tm1b(KOMP)Wtsi |
Clinical Chemistry | Calcium | homozygote | decreased circulating calcium level | 3.2687228923578004E-8 | ||
Etaa1 Etaa1em1(IMPC)Marc |
Hematology | Mean corpuscular hemoglobin | homozygote | decreased mean corpuscular hemoglobin | 3.333725118181974E-8 | ||
Ces1f Ces1ftm1b(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Skin color - whole body | homozygote | abnormal skin coloration | 3.38484582584897E-8 | ||
Esr2 Esr2em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | decreased bone mineral content | 3.408863591403133E-8 | ||
Prickle4 Prickle4em1(IMPC)Marc |
Clinical Chemistry | Alanine aminotransferase | homozygote | increased circulating alanine transaminase level | 3.453489227922546E-8 | ||
Ube2h Ube2htm1b(EUCOMM)Hmgu |
Acoustic Startle and Pre-pulse Inhibition (PPI) | Response amplitude - S | heterozygote | increased startle reflex | 3.5534704068140854E-8 | ||
Fbxl18 Fbxl18tm1b(EUCOMM)Hmgu |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 3.652850111279804E-8 | ||
Etaa1 Etaa1em1(IMPC)Marc |
Hematology | Hemoglobin | homozygote | decreased hemoglobin content | 4.0568011172581464E-8 | ||
Ints6l Ints6lem1(IMPC)Marc |
Echo | LVIDd | hemizygote | dilated heart left ventricle | 4.059633340602886E-8 | ||
Ints6l Ints6lem1(IMPC)Marc |
Echo | LVPWs | hemizygote | decreased heart left ventricle size | 4.42286598456576E-8 | ||
Fbxo36 Fbxo36tm1b(KOMP)Wtsi |
Hematology | Platelet count | homozygote | thrombocytopenia | 4.544811105233748E-8 | ||
Phf5a Phf5aem2(IMPC)Marc |
Hematology | Mean corpuscular hemoglobin | heterozygote | increased mean corpuscular hemoglobin | 4.550572541006659E-8 | ||
Cyp3a59 Cyp3a59em1(IMPC)Marc |
Hematology | Platelet count | heterozygote | thrombocytopenia | 4.620488525119981E-8 | ||
Ppp2r2a Ppp2r2atm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Bone Area | heterozygote | abnormal bone structure | 4.940050502000304E-8 | ||
Usp16 Usp16tm1b(EUCOMM)Hmgu |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 4.980431000944918E-8 | ||
Fbxo27 Fbxo27em2(IMPC)Marc |
Clinical Chemistry | Triglycerides | homozygote | increased circulating triglyceride level | 5.1214577467817435E-8 | ||
Ccdc83 Ccdc83em1(IMPC)Marc |
Hematology | White blood cell count | homozygote | decreased leukocyte cell number | 5.2914604253828657E-8 | ||
Fbxo10 Fbxo10tm1b(KOMP)Wtsi |
Echo | Ejection Fraction | homozygote | decreased cardiac muscle contractility | 5.302877426061059E-8 | ||
Ube2e1 Ube2e1em1(IMPC)Marc |
Hematology | Monocyte differential count | homozygote | increased monocyte cell number | 5.418711523930142E-8 | ||
Usp32 Usp32em1(IMPC)Mhzh |
Clinical Chemistry | Glucose | heterozygote | decreased circulating glucose level | 5.4728495513245434E-8 | ||
Usp40 Usp40em1(IMPC)Marc |
Grip Strength | Forelimb grip strength measurement mean | homozygote | decreased grip strength | 5.5936624221430975E-8 | ||
Hnrnpd Hnrnpdtm1b(KOMP)Wtsi |
Hematology | Lymphocyte cell count | heterozygote | decreased lymphocyte cell number | 5.5939143095429245E-8 | ||
Ctu2 Ctu2tm1(KOMP)Wtsi |
Hematology | Eosinophil cell count | heterozygote | increased eosinophil cell number | 5.932002622444088E-8 | ||
Ufc1 Ufc1em1(IMPC)Marc |
Hematology | Eosinophil cell count | heterozygote | increased eosinophil cell number | 5.99173120008345E-8 | ||
Psmd14 Psmd14tm1b(NCOM)Cmhd |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 6.211405434441986E-8 | ||
Phf5a Phf5aem2(IMPC)Marc |
Body Composition (DEXA lean/fat) | Fat/Body weight | heterozygote | decreased total body fat amount | 6.230742854995697E-8 | ||
Usp15 Usp15em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 6.278119712987973E-8 | ||
B3galt1 B3galt1em1(IMPC)Marc |
Clinical Chemistry | Creatinine | homozygote | decreased circulating creatinine level | 6.383312012303577E-8 | ||
Lypd2 Lypd2em1(IMPC)Marc |
Hematology | Lymphocyte differential count | homozygote | increased lymphocyte cell number | 6.491370641015237E-8 | ||
Kics2 Kics2tm1b(KOMP)Wtsi |
Clinical Chemistry | Phosphorus | homozygote | decreased circulating phosphate level | 6.55799681226199E-8 | ||
Otud6a Otud6atm1(KOMP)Vlcg |
Open Field | Center average speed | homozygote | hyperactivity | 6.561285204043088E-8 | ||
Prpf31 Prpf31tm1a(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | Lean mass | heterozygote | decreased lean body mass | 6.764510374068777E-8 | ||
Usp31 Usp31em1(IMPC)Marc |
Clinical Chemistry | Creatinine | homozygote | increased circulating creatinine level | 6.85463703575806E-8 | ||
Atg4b Atg4bem1(IMPC)Marc |
Clinical Chemistry | Alkaline phosphatase | homozygote | increased circulating alkaline phosphatase level | 7.075994545857611E-8 | ||
Apbb3 Apbb3em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 7.225502685059837E-8 | ||
Trim37 Trim37em1(IMPC)Marc |
Grip Strength | Forelimb grip strength measurement mean | homozygote | increased grip strength | 7.611351549030587E-8 | ||
Adarb1 Adarb1em1(IMPC)Marc |
Hematology | Hematocrit | heterozygote | increased hematocrit | 7.922461975340411E-8 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Eye Morphology | Retinal Blood Vessels Pattern | heterozygote | abnormal retina blood vessel morphology | 8.163083009549155E-8 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Eye Morphology | Persistence of hyaloid vascular system | heterozygote | persistence of hyaloid vascular system | 8.163083009549155E-8 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Eye Morphology | Retinal Blood Vessels Structure | heterozygote | abnormal retina blood vessel morphology | 8.163083009549155E-8 | ||
Gsdma3 Gsdma3tm1(KOMP)Vlcg |
Hematology | Lymphocyte cell count | homozygote | increased lymphocyte cell number | 8.311740629096676E-8 | ||
Fbxl8 Fbxl8em2(IMPC)Marc |
Hematology | Monocyte differential count | homozygote | increased monocyte cell number | 8.400895978866174E-8 | ||
Fshr Fshrtm1(KOMP)Vlcg |
Body Composition (DEXA lean/fat) | Lean/Body weight | homozygote | decreased lean body mass | 8.462875911163792E-8 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Hematology | Eosinophil cell count | heterozygote | increased eosinophil cell number | 8.933325545967818E-8 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Grip Strength | Forelimb and hindlimb grip strength measurement mean | heterozygote | decreased grip strength | 9.24734564478058E-8 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Clinical Chemistry | Creatinine | homozygote | increased circulating creatinine level | 9.642599252401851E-8 | ||
Ppp2r2a Ppp2r2atm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | heterozygote | decreased bone mineral content | 9.935833134022687E-8 | ||
Trim37 Trim37em1(IMPC)Marc |
Hematology | Lymphocyte cell count | homozygote | decreased lymphocyte cell number | 1.07501456625414E-7 | ||
Ppp1r14a Ppp1r14aem1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 1.1342416428306024E-7 | ||
Usp16 Usp16tm1b(EUCOMM)Hmgu |
Hematology | Eosinophil cell count | heterozygote | increased eosinophil cell number | 1.1449358794379805E-7 | ||
BC049715 BC049715tm1b(KOMP)Mbp |
Hematology | Red blood cell count | homozygote | decreased erythrocyte cell number | 1.1666918453556718E-7 | ||
Usp32 Usp32em1(IMPC)Mhzh |
Clinical Chemistry | Glucose | heterozygote | decreased circulating glucose level | 1.170250811810547E-7 | ||
Ppp2r2a Ppp2r2atm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Body length | heterozygote | decreased body length | 1.17693325307755E-7 | ||
Gsdma3 Gsdma3tm1(KOMP)Vlcg |
Hematology | Red blood cell count | homozygote | decreased erythrocyte cell number | 1.198652910261444E-7 | ||
Ccdc124 Ccdc124tm1b(KOMP)Wtsi |
Open Field | Whole arena resting time | homozygote | hyperactivity | 1.2153412853876944E-7 | ||
Ppp2r2a Ppp2r2atm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | heterozygote | decreased bone mineral content | 1.23036230093021E-7 | ||
Atg4c Atg4cem2(IMPC)Marc |
Hematology | Neutrophil differential count | homozygote | increased neutrophil cell number | 1.2396255044677673E-7 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Body Composition (DEXA lean/fat) | Body length | homozygote | decreased body length | 1.244714269432734E-7 | ||
Fshr Fshrtm1(KOMP)Vlcg |
Body Composition (DEXA lean/fat) | Fat/Body weight | homozygote | increased total body fat amount | 1.2537437044102262E-7 | ||
Bnip1 Bnip1tm2b(KOMP)Wtsi |
Open Field | Latency to center entry | heterozygote | decreased exploration in new environment | 1.3902877071814146E-7 | ||
Phf5a Phf5aem2(IMPC)Marc |
Hematology | Mean platelet volume | heterozygote | increased mean platelet volume | 1.4092790934228105E-7 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Eye Morphology | Retinal Blood Vessels | heterozygote | abnormal retina vasculature morphology | 1.6222274723531882E-7 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Eye Morphology | Optic Disc | heterozygote | abnormal optic disk morphology | 1.6222274723531882E-7 | ||
Eddm3b Eddm3btm1b(KOMP)Wtsi |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 1.635779085518152E-7 | ||
Zdhhc2 Zdhhc2tm1b(KOMP)Wtsi |
Echo | LVIDd | homozygote | dilated heart left ventricle | 1.6428371907295514E-7 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | Red blood cell count | homozygote | increased erythrocyte cell number | 1.706667944745277E-7 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Clinical Chemistry | Total cholesterol | homozygote | increased circulating cholesterol level | 1.7741845681484847E-7 | ||
Kdm2b Kdm2bem1(IMPC)Marc |
Hematology | Neutrophil cell count | heterozygote | increased neutrophil cell number | 1.808108720524615E-7 | ||
Ppp1cb Ppp1cbem2(IMPC)Marc |
Open Field | Latency to center entry | heterozygote | decreased exploration in new environment | 1.8210069185897737E-7 | ||
Brcc3 Brcc3em1(IMPC)Marc |
Hematology | Mean corpuscular hemoglobin | homozygote | increased mean corpuscular hemoglobin | 1.826171853736014E-7 | ||
Herc6 Herc6tm1b(EUCOMM)Hmgu |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 1.8915805810593156E-7 | ||
Bbc3 Bbc3em1(IMPC)Marc |
Hematology | Mean corpuscular hemoglobin | homozygote | increased mean corpuscular hemoglobin | 1.9286390795514308E-7 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Clinical Chemistry | Urea (Blood Urea Nitrogen - BUN) | heterozygote | decreased blood urea nitrogen level | 1.9567080755678035E-7 | ||
Cdc42ep5 Cdc42ep5tm1(KOMP)Wtsi |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 2.007166273187977E-7 | ||
Lypd2 Lypd2em1(IMPC)Marc |
Hematology | Neutrophil cell count | homozygote | decreased neutrophil cell number | 2.0486896801230614E-7 | ||
Aars2 Aars2tm1(KOMP)Wtsi |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 2.0546876555727067E-7 | ||
Mir203 Mir203tm1Wtsi |
Open Field | Latency to center entry | heterozygote | decreased exploration in new environment | 2.17482295283844E-7 | ||
Zfp36 Zfp36tm1(KOMP)Vlcg |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | heterozygote | increased fasting circulating glucose level | 2.209490190807628E-7 | ||
Bola2 Bola2tm1(KOMP)Wtsi |
Hematology | Mean cell volume | homozygote | decreased mean corpuscular volume | 2.2254185694237094E-7 | ||
Fbxw13 Fbxw13em2(IMPC)Marc |
Hematology | Mean corpuscular hemoglobin | homozygote | increased mean corpuscular hemoglobin | 2.2457886927895743E-7 | ||
Aars2 Aars2tm1(KOMP)Wtsi |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 2.2560415402494982E-7 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Open Field | Whole arena average speed | heterozygote | decreased locomotor activity | 2.2993103243607038E-7 | ||
Cyp3a59 Cyp3a59em1(IMPC)Marc |
Hematology | Mean platelet volume | heterozygote | decreased mean platelet volume | 2.3427840289969026E-7 | ||
Fshr Fshrtm1(KOMP)Vlcg |
Body Composition (DEXA lean/fat) | Fat mass | homozygote | increased total body fat amount | 2.3717244346244115E-7 | ||
Ces2e Ces2eem1(IMPC)Marc |
Clinical Chemistry | Creatinine | homozygote | increased circulating creatinine level | 2.3928021164465463E-7 | ||
Hnrnph1 Hnrnph1tm1b(KOMP)Wtsi |
Hematology | Lymphocyte cell count | heterozygote | increased lymphocyte cell number | 2.602583606403641E-7 | ||
Ppp2r5e Ppp2r5eem1(IMPC)Marc |
Hematology | Mean cell hemoglobin concentration | homozygote | decreased mean corpuscular hemoglobin concentration | 2.6049460188914964E-7 | ||
Atp13a5 Atp13a5em1(IMPC)Marc |
Grip Strength | Forelimb and hindlimb grip strength normalised against body weight | homozygote | increased grip strength | 2.6225410465485766E-7 | ||
Otud6a Otud6atm1(KOMP)Vlcg |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 2.7425292614680075E-7 | ||
Fbxo10 Fbxo10tm1b(KOMP)Wtsi |
Hematology | Mean corpuscular hemoglobin | homozygote | decreased mean corpuscular hemoglobin | 2.778558041427459E-7 | ||
Atg4a Atg4aem2(IMPC)Marc |
Body Composition (DEXA lean/fat) | Lean/Body weight | homozygote | decreased lean body mass | 2.8449855449252937E-7 | ||
Bod1 Bod1tm1b(KOMP)Wtsi |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 2.8656452855102543E-7 | ||
Bend3 Bend3tm1b(KOMP)Mbp |
Combined SHIRPA and Dysmorphology | Coat - color - head | heterozygote | abnormal coat/hair pigmentation | 2.89185891233501E-7 | ||
Dusp7 Dusp7tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Coat - color pattern - head | homozygote | abnormal coat/hair pigmentation | 2.954453748316155E-7 | ||
Ube2d3 Ube2d3tm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | BMC/Body weight | heterozygote | decreased bone mineral content | 2.9842510684829904E-7 | ||
Atg4a Atg4aem2(IMPC)Marc |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | decreased bone mineral content | 2.9869909212720813E-7 | ||
Fbxo24 Fbxo24em2(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 3.076948473790253E-7 | ||
Cdc42ep5 Cdc42ep5tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Coat - color - head | homozygote | abnormal coat/hair pigmentation | 3.130067796064395E-7 | ||
Bnip1 Bnip1tm2b(KOMP)Wtsi |
Hematology | Eosinophil differential count | heterozygote | increased eosinophil cell number | 3.1318126048063277E-7 | ||
Kics2 Kics2tm1b(KOMP)Wtsi |
Clinical Chemistry | Urea (Blood Urea Nitrogen - BUN) | homozygote | increased blood urea nitrogen level | 3.150096574700001E-7 | ||
Fbxo36 Fbxo36tm1b(KOMP)Wtsi |
Hematology | Monocyte differential count | homozygote | decreased monocyte cell number | 3.3992449743891484E-7 | ||
Esr2 Esr2em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | BMC/Body weight | homozygote | decreased bone mineral content | 3.6189757679494505E-7 | ||
Pfkfb2 Pfkfb2tm1b(KOMP)Wtsi |
Echo | LVAWs | homozygote | thin ventricular wall | 3.694491397254751E-7 | ||
Herc6 Herc6tm1b(EUCOMM)Hmgu |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 3.756085504846851E-7 | ||
Esr2 Esr2em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | homozygote | decreased bone mineral density | 3.784584521326906E-7 | ||
Bend3 Bend3tm1b(KOMP)Mbp |
Combined SHIRPA and Dysmorphology | Coat - color - abdomen | heterozygote | abnormal coat/hair pigmentation | 3.785830813285429E-7 | ||
Aars2 Aars2tm1(KOMP)Wtsi |
Echo | LVIDd | heterozygote | abnormal heart left ventricle morphology | 3.786310571740614E-7 | ||
Ints6l Ints6lem1(IMPC)Marc |
Echo | Fractional Shortening | hemizygote | decreased cardiac muscle contractility | 3.9675407492723025E-7 | ||
Cdc42ep5 Cdc42ep5tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Coat - color - abdomen | homozygote | abnormal coat/hair pigmentation | 4.040675207761524E-7 | ||
Phf5a Phf5aem2(IMPC)Marc |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | heterozygote | increased bone mineral content | 4.1605250089560286E-7 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Open Field | Periphery average speed | heterozygote | decreased locomotor activity | 4.2798774302355014E-7 | ||
Uchl5 Uchl5tm1(NCOM)Mfgc |
Open Field | Whole arena average speed | heterozygote | decreased locomotor activity | 4.2851752368733287E-7 | ||
Fbxo15 Fbxo15em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 4.338470489528845E-7 | ||
Fbxw8 Fbxw8tm1b(EUCOMM)Hmgu |
Hematology | Lymphocyte differential count | heterozygote | decreased lymphocyte cell number | 4.610863300058554E-7 | ||
Cntn3 Cntn3em1(IMPC)Marc |
Echo | LVPWs | homozygote | thick ventricular wall | 4.6905486783543893E-7 | ||
Fbxo36 Fbxo36tm1b(KOMP)Wtsi |
Echo | LVPWd | homozygote | thick ventricular wall | 4.847676677854906E-7 | ||
Atg4a Atg4aem2(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 4.855453425989253E-7 | ||
Fbxo38 Fbxo38em2(IMPC)Marc |
Body Composition (DEXA lean/fat) | Body length | homozygote | decreased body length | 5.025020186621987E-7 | ||
Trim37 Trim37em1(IMPC)Marc |
Hematology | White blood cell count | homozygote | decreased leukocyte cell number | 5.516156988960574E-7 | ||
Phf5a Phf5aem2(IMPC)Marc |
Body Composition (DEXA lean/fat) | Lean/Body weight | heterozygote | increased lean body mass | 5.550033392864862E-7 | ||
Ppp2r5e Ppp2r5eem1(IMPC)Marc |
Hematology | Mean platelet volume | homozygote | decreased mean platelet volume | 5.578144737228286E-7 | ||
Atg4c Atg4cem2(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 5.797951985186955E-7 | ||
Brcc3 Brcc3em1(IMPC)Marc |
Hematology | Mean platelet volume | homozygote | increased mean platelet volume | 5.920801413594745E-7 | ||
Cyld Cyldem2(IMPC)Marc |
Open Field | Number of center entries | homozygote | decreased locomotor activity | 6.053981564946298E-7 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Grip Strength | Forelimb grip strength measurement mean | homozygote | decreased grip strength | 6.065786806175311E-7 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | decreased bone mineral content | 6.766269962099614E-7 | ||
Fbxo15 Fbxo15em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 7.118576377251884E-7 | ||
Fbxo10 Fbxo10tm1b(KOMP)Wtsi |
Clinical Chemistry | Urea (Blood Urea Nitrogen - BUN) | homozygote | decreased blood urea nitrogen level | 7.481643820028694E-7 | ||
Dbil5 Dbil5tm1(KOMP)Wtsi |
Clinical Chemistry | Alkaline phosphatase | homozygote | increased circulating alkaline phosphatase level | 7.570858429062355E-7 | ||
Fbxl19 Fbxl19tm1b(EUCOMM)Wtsi |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 7.58289559144032E-7 | ||
Brcc3 Brcc3em1(IMPC)Marc |
Hematology | Platelet count | homozygote | thrombocytosis | 7.707414511060051E-7 | ||
Itprid1 Itprid1em1(IMPC)Marc |
Hematology | Neutrophil cell count | homozygote | increased neutrophil cell number | 7.763305234220752E-7 | ||
Dtl Dtltm1b(EUCOMM)Wtsi |
Grip Strength | Forelimb and hindlimb grip strength measurement mean | heterozygote | decreased grip strength | 8.056293836489203E-7 | ||
Senp7 Senp7tm1b(EUCOMM)Hmgu |
Combined SHIRPA and Dysmorphology | Coat - color - head | homozygote | abnormal coat/hair pigmentation | 8.126598913804628E-7 | ||
Uchl5 Uchl5tm1(NCOM)Mfgc |
Open Field | Periphery average speed | heterozygote | decreased locomotor activity | 8.213556270675326E-7 | ||
Fbxo43 Fbxo43em1(IMPC)Marc |
Hematology | Red blood cell count | homozygote | increased erythrocyte cell number | 8.298895863845246E-7 | ||
Acsm1 Acsm1em1(IMPC)Mhzh |
Open Field | Latency to center entry | homozygote | decreased exploration in new environment | 8.360973993148946E-7 | ||
Phf5a Phf5aem2(IMPC)Marc |
Hematology | Mean corpuscular hemoglobin | heterozygote | increased mean corpuscular hemoglobin | 8.376457572012441E-7 | ||
Lsm14a Lsm14atm1b(KOMP)Wtsi |
Hematology | Hemoglobin | heterozygote | decreased hemoglobin content | 8.428598334830895E-7 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Open Field | Center distance travelled | heterozygote | decreased locomotor activity | 8.779321660767891E-7 | ||
Mir350 Mir350tm1Wtsi |
Echo | LVIDd | homozygote | abnormal heart left ventricle morphology | 8.785536351751944E-7 | ||
Dusp7 Dusp7tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Coat - color pattern - back | homozygote | abnormal coat/hair pigmentation | 8.798989483693731E-7 | ||
Alg1 Alg1tm1b(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Coat - color pattern - back | heterozygote | abnormal coat/hair pigmentation | 8.798989483693731E-7 | ||
Atg4a Atg4aem2(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 8.904926289687864E-7 | ||
Ube2z Ube2zem1(IMPC)Marc |
Hematology | Eosinophil cell count | heterozygote | increased eosinophil cell number | 9.010527719510719E-7 | ||
Ppp2r2a Ppp2r2atm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | heterozygote | decreased bone mineral density | 9.548019761496107E-7 | ||
Lsm14a Lsm14atm1b(KOMP)Wtsi |
Hematology | Hematocrit | heterozygote | decreased hematocrit | 9.755062819749583E-7 | ||
Ins1 Ins1em1(IMPC)Marc |
Open Field | Latency to center entry | homozygote | decreased exploration in new environment | 9.842467534326715E-7 | ||
Etaa1 Etaa1em1(IMPC)Marc |
Hematology | Mean platelet volume | homozygote | increased mean platelet volume | 9.896072015180835E-7 | ||
Phf5a Phf5aem2(IMPC)Marc |
Hematology | Red blood cell count | heterozygote | decreased erythrocyte cell number | 9.921664059220348E-7 | ||
Kmt2c Kmt2cem2(IMPC)Marc |
Eye Morphology | Retina (combined) | heterozygote | abnormal retina morphology | 9.942283440977917E-7 | ||
Ppp1r1a Ppp1r1aem2(IMPC)Marc |
Body Composition (DEXA lean/fat) | Body length | homozygote | increased body length | 1.0187977750319988E-6 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | Hematocrit | homozygote | decreased hematocrit | 1.0401563486084342E-6 | ||
Senp7 Senp7tm1b(EUCOMM)Hmgu |
Combined SHIRPA and Dysmorphology | Coat - color - abdomen | homozygote | abnormal coat/hair pigmentation | 1.0477907608219539E-6 | ||
Atg4a Atg4aem2(IMPC)Marc |
Body Composition (DEXA lean/fat) | Fat mass | homozygote | increased total body fat amount | 1.0484210406502825E-6 | ||
Hnrnpd Hnrnpdtm1b(KOMP)Wtsi |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 1.0664517731129308E-6 | ||
Usp15 Usp15em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 1.080178208212601E-6 | ||
Cpa1 Cpa1em1(IMPC)Marc |
Hematology | Mean cell volume | homozygote | increased mean corpuscular volume | 1.0856920198420994E-6 | ||
Pfkfb2 Pfkfb2tm1b(KOMP)Wtsi |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 1.0872247457882622E-6 | ||
Fbxo36 Fbxo36tm1b(KOMP)Wtsi |
Hematology | Monocyte differential count | homozygote | decreased monocyte cell number | 1.0956119922411744E-6 | ||
Usp30 Usp30em1(IMPC)Marc |
Auditory Brain Stem Response | Click-evoked ABR threshold | homozygote | abnormal auditory brainstem response | 1.1298487834210391E-6 | ||
Senp7 Senp7tm1b(EUCOMM)Hmgu |
Acoustic Startle and Pre-pulse Inhibition (PPI) | Response amplitude - S | homozygote | increased startle reflex | 1.1305482985335402E-6 | ||
Itprid1 Itprid1em1(IMPC)Marc |
Hematology | Lymphocyte differential count | homozygote | decreased lymphocyte cell number | 1.1322904356347863E-6 | ||
Fbxo43 Fbxo43em1(IMPC)Marc |
Hematology | Mean platelet volume | homozygote | increased mean platelet volume | 1.1345323400746565E-6 | ||
Lsm14a Lsm14atm1b(KOMP)Wtsi |
Hematology | Red blood cell count | heterozygote | decreased erythrocyte cell number | 1.186922190754558E-6 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Intraperitoneal glucose tolerance test (IPGTT) | Area under glucose response curve | homozygote | improved glucose tolerance | 1.2127381978643825E-6 | ||
Fancl Fancltm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | Fat/Body weight | homozygote | increased total body fat amount | 1.212831534758152E-6 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Combined SHIRPA and Dysmorphology | Vocalization | homozygote | abnormal vocalization | 1.238866275343753E-6 | ||
Itprid1 Itprid1em1(IMPC)Marc |
Hematology | Mean platelet volume | homozygote | increased mean platelet volume | 1.2523955774668138E-6 | ||
Ints6l Ints6lem1(IMPC)Marc |
Echo | LVAWs | hemizygote | thin ventricular wall | 1.2641114608413773E-6 | ||
Lypd2 Lypd2em1(IMPC)Marc |
Hematology | Monocyte cell count | homozygote | decreased monocyte cell number | 1.313927555202099E-6 | ||
Trim37 Trim37em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Bone Area | homozygote | abnormal bone structure | 1.3152117617210024E-6 | ||
Kics2 Kics2tm1b(KOMP)Wtsi |
Clinical Chemistry | Total cholesterol | homozygote | decreased circulating cholesterol level | 1.3201232604842517E-6 | ||
Ube2z Ube2zem1(IMPC)Marc |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 1.3450916185320239E-6 | ||
Hectd4 Hectd4em1(IMPC)Marc |
Clinical Chemistry | Glucose | heterozygote | decreased circulating glucose level | 1.350991851722938E-6 | ||
Alg1 Alg1tm1b(KOMP)Wtsi |
Clinical Chemistry | Cholesterol ratio | heterozygote | abnormal cholesterol homeostasis | 1.3704883485843311E-6 | ||
Ppp2r3a Ppp2r3atm1(KOMP)Mbp |
Clinical Chemistry | Alkaline phosphatase | homozygote | increased circulating alkaline phosphatase level | 1.390053967043059E-6 | ||
Bap1 Bap1em2(IMPC)Marc |
Hematology | Eosinophil cell count | heterozygote | increased eosinophil cell number | 1.3917631349613657E-6 | ||
Etaa1 Etaa1em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 1.3988760656502564E-6 | ||
Prickle4 Prickle4em1(IMPC)Marc |
Clinical Chemistry | Glucose | homozygote | decreased circulating glucose level | 1.419308318872936E-6 | ||
Hnrnpd Hnrnpdtm1b(KOMP)Wtsi |
Hematology | White blood cell count | heterozygote | decreased leukocyte cell number | 1.440633241145406E-6 | ||
Cdc42ep5 Cdc42ep5tm1(KOMP)Wtsi |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 1.4779263892705785E-6 | ||
Usp31 Usp31em1(IMPC)Marc |
Open Field | Whole arena resting time | homozygote | decreased locomotor activity | 1.4845367104499019E-6 | ||
Cdc42ep5 Cdc42ep5tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Coat - color - back | homozygote | abnormal coat/hair pigmentation | 1.4857088217468117E-6 | ||
Fbxo22 Fbxo22tm1b(EUCOMM)Wtsi |
Grip Strength | Forelimb and hindlimb grip strength measurement mean | homozygote | decreased grip strength | 1.5057413520480623E-6 | ||
Hnrnpr Hnrnprem1(IMPC)Marc |
Hematology | Red blood cell distribution width | homozygote | decreased red blood cell distribution width | 1.5950035958667286E-6 | ||
Ash1l Ash1ltm2b(EUCOMM)Hmgu |
Combined SHIRPA and Dysmorphology | Coat - hair texture / appearance - back | heterozygote | abnormal coat appearance | 1.6908385305214324E-6 | ||
Itprid1 Itprid1em1(IMPC)Marc |
Hematology | Monocyte cell count | homozygote | increased monocyte cell number | 1.7201508626385476E-6 | ||
Ccdc83 Ccdc83em1(IMPC)Marc |
Echo | LVPWd | homozygote | thin ventricular wall | 1.7648841321715736E-6 | ||
Pfkfb2 Pfkfb2tm1b(KOMP)Wtsi |
Echo | LVAWs | homozygote | thin ventricular wall | 1.8126954728359124E-6 | ||
Zfp36 Zfp36tm1(KOMP)Vlcg |
Hematology | Mean cell volume | heterozygote | decreased mean corpuscular volume | 1.8369937606621534E-6 | ||
Kdm2b Kdm2bem1(IMPC)Marc |
Clinical Chemistry | Albumin | heterozygote | decreased circulating serum albumin level | 1.8460766568750842E-6 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Grip Strength | Forelimb and hindlimb grip strength normalised against body weight | heterozygote | increased grip strength | 1.890629505396646E-6 | ||
Kmt2c Kmt2cem2(IMPC)Marc |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | heterozygote | increased bone mineral content | 1.8981487528435537E-6 | ||
Ppp2r3a Ppp2r3atm1(KOMP)Mbp |
Grip Strength | Forelimb grip strength measurement mean | homozygote | decreased grip strength | 1.9269882614025846E-6 | ||
Fbxo38 Fbxo38em2(IMPC)Marc |
Hematology | Mean platelet volume | homozygote | increased mean platelet volume | 1.951347258000169E-6 | ||
Esr2 Esr2em1(IMPC)Marc |
Hematology | Lymphocyte cell count | homozygote | decreased lymphocyte cell number | 2.011701553783496E-6 | ||
Lsm14a Lsm14atm1b(KOMP)Wtsi |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 2.0406882867973763E-6 | ||
Fbxw2 Fbxw2tm1b(EUCOMM)Hmgu |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 2.0890176983812125E-6 | ||
Kmt2c Kmt2cem2(IMPC)Marc |
Body Composition (DEXA lean/fat) | Bone Area | heterozygote | abnormal bone structure | 2.111625917677884E-6 | ||
Fbxo38 Fbxo38em2(IMPC)Marc |
Open Field | Periphery distance travelled | homozygote | decreased locomotor activity | 2.1428570562420646E-6 | ||
Bend3 Bend3tm1b(KOMP)Mbp |
Combined SHIRPA and Dysmorphology | Coat - color - back | heterozygote | abnormal coat/hair pigmentation | 2.1642019873979734E-6 | ||
Ppp2r5e Ppp2r5eem1(IMPC)Marc |
Open Field | Center average speed | homozygote | decreased locomotor activity | 2.2044721390557243E-6 | ||
Usp16 Usp16tm1b(EUCOMM)Hmgu |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 2.2225842712941812E-6 | ||
Slco6c1 Slco6c1em1(IMPC)Marc |
Clinical Chemistry | Phosphorus | homozygote | decreased circulating phosphate level | 2.25385042540438E-6 | ||
Dusp7 Dusp7tm1(KOMP)Wtsi |
Clinical Chemistry | Total cholesterol | homozygote | decreased circulating cholesterol level | 2.2697861368214944E-6 | ||
Fbxw13 Fbxw13em2(IMPC)Marc |
Hematology | Red blood cell distribution width | homozygote | decreased red blood cell distribution width | 2.278341526107397E-6 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Open Field | Number of center entries | heterozygote | decreased locomotor activity | 2.323189164599171E-6 | ||
Usp31 Usp31em1(IMPC)Marc |
Open Field | Periphery resting time | homozygote | decreased locomotor activity | 2.3349948605755344E-6 | ||
Fbxl2 Fbxl2em2(IMPC)Marc |
Hematology | Red blood cell distribution width | homozygote | decreased red blood cell distribution width | 2.3439820324711036E-6 | ||
Fbxo22 Fbxo22tm1b(EUCOMM)Wtsi |
Echo | LVPWd | heterozygote | thin ventricular wall | 2.3733307443762897E-6 | ||
Gsdma3 Gsdma3tm1(KOMP)Vlcg |
Hematology | Hematocrit | homozygote | decreased hematocrit | 2.3967813831404783E-6 | ||
Arel1 Arel1tm1b(EUCOMM)Hmgu |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | homozygote | increased fasting circulating glucose level | 2.4530725113436347E-6 | ||
Crisp3 Crisp3em1(IMPC)Mhzh |
Eye Morphology | Retina (combined) | homozygote | abnormal retina morphology | 2.4655632842041086E-6 | ||
Atg4b Atg4bem1(IMPC)Marc |
Eye Morphology | Retina (combined) | homozygote | abnormal retina morphology | 2.4655632842041086E-6 | ||
Wfdc11 Wfdc11em1(IMPC)Marc |
Eye Morphology | Retina (combined) | homozygote | abnormal retina morphology | 2.4655632842041086E-6 | ||
Trim37 Trim37em1(IMPC)Marc |
Eye Morphology | Retina (combined) | homozygote | abnormal retina morphology | 2.4655632842041086E-6 | ||
Pfkfb2 Pfkfb2tm1b(KOMP)Wtsi |
Eye Morphology | Retina (combined) | homozygote | abnormal retina morphology | 2.4655632842041086E-6 | ||
Atg4d Atg4dem1(IMPC)Marc |
Eye Morphology | Retina (combined) | homozygote | abnormal retina morphology | 2.4655632842041086E-6 | ||
Kmt2a Kmt2aem1(IMPC)Marc |
Eye Morphology | Retina (combined) | heterozygote | abnormal retina morphology | 2.4655632842041086E-6 | ||
Hectd4 Hectd4em1(IMPC)Marc |
Eye Morphology | Retina (combined) | heterozygote | abnormal retina morphology | 2.4655632842041086E-6 | ||
Ube2e1 Ube2e1em1(IMPC)Marc |
Eye Morphology | Retina (combined) | homozygote | abnormal retina morphology | 2.4655632842041086E-6 | ||
Pfkfb2 Pfkfb2tm1b(KOMP)Wtsi |
Hematology | Neutrophil differential count | homozygote | decreased neutrophil cell number | 2.494431555533083E-6 | ||
Fbxl19 Fbxl19tm1b(EUCOMM)Wtsi |
Clinical Chemistry | Total protein | heterozygote | decreased circulating total protein level | 2.4944795313786017E-6 | ||
Htr2b Htr2btm1b(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | Fat/Body weight | heterozygote | increased total body fat amount | 2.5483152512606466E-6 | ||
Prickle4 Prickle4em1(IMPC)Marc |
Open Field | Periphery resting time | homozygote | decreased locomotor activity | 2.5555764295859262E-6 | ||
Ube2z Ube2zem1(IMPC)Marc |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 2.567055389590678E-6 | ||
Fancl Fancltm1b(EUCOMM)Hmgu |
Combined SHIRPA and Dysmorphology | Coat - color - head | homozygote | abnormal coat/hair pigmentation | 2.627422190926154E-6 | ||
Fbxo36 Fbxo36tm1b(KOMP)Wtsi |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 2.7303888145979727E-6 | ||
Cimip2b Cimip2btm1(KOMP)Wtsi |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 2.759690460152342E-6 | ||
Ints6l Ints6lem1(IMPC)Marc |
Echo | Ejection Fraction | hemizygote | decreased cardiac muscle contractility | 2.8151553124189377E-6 | ||
Vav2 Vav2em1(IMPC)Marc |
Open Field | Number of center entries | homozygote | hyperactivity | 2.822590204232256E-6 | ||
Ufm1 Ufm1em1(IMPC)Marc |
Echo | Ejection Fraction | heterozygote | decreased cardiac muscle contractility | 2.831342271747417E-6 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Hematology | Mean platelet volume | heterozygote | increased mean platelet volume | 2.8425308755686274E-6 | ||
Phf5a Phf5aem2(IMPC)Marc |
Body Composition (DEXA lean/fat) | Bone Area | heterozygote | abnormal bone structure | 2.853973001037957E-6 | ||
Ppp2r3a Ppp2r3atm1(KOMP)Mbp |
Grip Strength | Forelimb grip strength measurement mean | homozygote | decreased grip strength | 2.8621554974961327E-6 | ||
Fbxw8 Fbxw8tm1b(EUCOMM)Hmgu |
Hematology | Neutrophil differential count | heterozygote | increased neutrophil cell number | 2.932275720013422E-6 | ||
Kmt2a Kmt2aem1(IMPC)Marc |
Echo | HR | heterozygote | increased heart rate | 2.9512648325180635E-6 | ||
Rabggta Rabggtatm1.1(KOMP)Vlcg |
Hematology | Hemoglobin | heterozygote | increased hemoglobin content | 2.958835239041946E-6 | ||
Ufm1 Ufm1em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Lean mass | heterozygote | decreased lean body mass | 3.0074086225795327E-6 | ||
Acsm1 Acsm1em1(IMPC)Mhzh |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 3.1252598091668915E-6 | ||
Herc4 Herc4tm1b(KOMP)Wtsi |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 3.15673355544277E-6 | ||
Prdm2 Prdm2em1(IMPC)Marc |
Clinical Chemistry | Creatinine | homozygote | increased circulating creatinine level | 3.179797658958705E-6 | ||
Fbxo36 Fbxo36tm1b(KOMP)Wtsi |
Echo | LVIDd | homozygote | abnormal heart left ventricle morphology | 3.1944125566951698E-6 | ||
Erich2 Erich2em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 3.2848090540937847E-6 | ||
Etaa1 Etaa1em1(IMPC)Marc |
Hematology | Red blood cell distribution width | homozygote | increased red blood cell distribution width | 3.3581000025151297E-6 | ||
Ube2w Ube2wtm1b(EUCOMM)Wtsi |
Auditory Brain Stem Response | Click-evoked ABR threshold | homozygote | abnormal auditory brainstem response | 3.3635128602327313E-6 | ||
Bbc3 Bbc3em1(IMPC)Marc |
Open Field | Center distance travelled | homozygote | hyperactivity | 3.455286105236155E-6 | ||
Tmem63a Tmem63atm1(KOMP)Vlcg |
Combined SHIRPA and Dysmorphology | Gait | homozygote | abnormal gait | 3.459442268649582E-6 | ||
Apbb3 Apbb3em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 3.5145881156495307E-6 | ||
Fbxl5 Fbxl5em1(IMPC)Marc |
Clinical Chemistry | Triglycerides | heterozygote | increased circulating triglyceride level | 3.526190539560048E-6 | ||
Bap1 Bap1em2(IMPC)Marc |
Combined SHIRPA and Dysmorphology | Vocalization | heterozygote | abnormal vocalization | 3.5507457596395398E-6 | ||
Phf5a Phf5aem2(IMPC)Marc |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | heterozygote | increased bone mineral content | 3.5795919757219963E-6 | ||
Fancl Fancltm1b(EUCOMM)Hmgu |
Combined SHIRPA and Dysmorphology | Coat - color - abdomen | homozygote | abnormal coat/hair pigmentation | 3.635483153630048E-6 | ||
Fbxl19 Fbxl19tm1b(EUCOMM)Wtsi |
Clinical Chemistry | Glucose | heterozygote | decreased circulating glucose level | 3.654288320831256E-6 | ||
Ints6l Ints6lem1(IMPC)Marc |
Echo | LVAWd | hemizygote | decreased heart left ventricle size | 3.6880196603306103E-6 | ||
Fshr Fshrtm1(KOMP)Vlcg |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | decreased bone mineral content | 3.7589304611174157E-6 | ||
Atg4a Atg4aem2(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 3.8094374303909717E-6 | ||
Zdhhc2 Zdhhc2tm1b(KOMP)Wtsi |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | homozygote | increased fasting circulating glucose level | 3.8142691209941404E-6 | ||
Senp7 Senp7tm1b(EUCOMM)Hmgu |
Combined SHIRPA and Dysmorphology | Coat - color - back | homozygote | abnormal coat/hair pigmentation | 3.824154646281386E-6 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Hematology | Mean platelet volume | heterozygote | increased mean platelet volume | 3.9592709981661756E-6 | ||
Ppp2r2a Ppp2r2atm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | BMC/Body weight | heterozygote | decreased bone mineral content | 3.9893229768495075E-6 | ||
Chst12 Chst12em1(IMPC)Marc |
Hematology | Lymphocyte cell count | homozygote | decreased lymphocyte cell number | 4.105274001631187E-6 | ||
Lypd2 Lypd2em1(IMPC)Marc |
Hematology | Neutrophil differential count | homozygote | decreased neutrophil cell number | 4.134524260734906E-6 | ||
Erich2 Erich2em1(IMPC)Marc |
Grip Strength | Forelimb grip strength measurement mean | homozygote | decreased grip strength | 4.144332251598826E-6 | ||
Lypd2 Lypd2em1(IMPC)Marc |
Hematology | Platelet count | homozygote | thrombocytopenia | 4.202847776468843E-6 | ||
Usp31 Usp31em1(IMPC)Marc |
Grip Strength | Forelimb grip strength measurement mean | homozygote | decreased grip strength | 4.356355930212885E-6 | ||
Hnrnpr Hnrnprem1(IMPC)Marc |
Combined SHIRPA and Dysmorphology | Locomotor activity | homozygote | decreased exploration in new environment | 4.369263024273096E-6 | ||
B3galt1 B3galt1em1(IMPC)Marc |
Combined SHIRPA and Dysmorphology | Activity (body position) | homozygote | abnormal locomotor behavior | 4.408454969961895E-6 | ||
Nxn Nxntm1b(EUCOMM)Wtsi |
Eye Morphology | Optic Disc | heterozygote | abnormal optic disk morphology | 4.450045253179269E-6 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Open Field | Periphery resting time | heterozygote | decreased locomotor activity | 4.4920147956872825E-6 | ||
Etaa1 Etaa1em1(IMPC)Marc |
Hematology | Lymphocyte cell count | homozygote | increased lymphocyte cell number | 4.603292836691253E-6 | ||
Ctu2 Ctu2tm1(KOMP)Wtsi |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 4.674932370107854E-6 | ||
Fbxl19 Fbxl19tm1b(EUCOMM)Wtsi |
Hematology | Eosinophil cell count | heterozygote | increased eosinophil cell number | 4.759564490086632E-6 | ||
Abhd3 Abhd3em1(IMPC)Marc |
Echo | LVPWs | homozygote | decreased heart left ventricle size | 4.89812737214379E-6 | ||
Trim37 Trim37em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 4.990130491933087E-6 | ||
Fbxo43 Fbxo43em1(IMPC)Marc |
Heart Weight | Heart weight | homozygote | increased heart weight | 5.047370905231219E-6 | ||
Ces2e Ces2eem1(IMPC)Marc |
Hematology | Red blood cell count | homozygote | decreased erythrocyte cell number | 5.048211278335657E-6 | ||
Mir203 Mir203tm1Wtsi |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | heterozygote | increased fasting circulating glucose level | 5.2000746109115425E-6 | ||
Fbxo10 Fbxo10tm1b(KOMP)Wtsi |
Hematology | Hematocrit | homozygote | decreased hematocrit | 5.206452897255076E-6 | ||
Dagla Daglatm1a(EUCOMM)Wtsi |
Acoustic Startle and Pre-pulse Inhibition (PPI) | Response amplitude - S | homozygote | increased startle reflex | 5.265132585918764E-6 | ||
Ints6l Ints6lem1(IMPC)Marc |
Clinical Chemistry | Triglycerides | homozygote | increased circulating triglyceride level | 5.311852874001488E-6 | ||
Ppp2r5e Ppp2r5eem1(IMPC)Marc |
Hematology | Hematocrit | homozygote | increased hematocrit | 5.3904236665403005E-6 | ||
Alg1 Alg1tm1b(KOMP)Wtsi |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 5.444424914458068E-6 | ||
Fbxo28 Fbxo28em1(IMPC)Mhzh |
Grip Strength | Forelimb grip strength measurement mean | heterozygote | increased grip strength | 5.464228706841823E-6 | ||
Phf21b Phf21bem1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 5.51503899259842E-6 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | Lean/Body weight | heterozygote | increased lean body mass | 5.7512229432177264E-6 | ||
Usp47 Usp47tm1b(EUCOMM)Wtsi |
Clinical Chemistry | Glucose | homozygote | increased circulating glucose level | 5.854339178767987E-6 | ||
Ufm1 Ufm1em1(IMPC)Marc |
Clinical Chemistry | Triglycerides | heterozygote | increased circulating triglyceride level | 5.939935817877995E-6 | ||
Dusp7 Dusp7tm1(KOMP)Wtsi |
Clinical Chemistry | Cholesterol ratio | homozygote | abnormal cholesterol homeostasis | 5.9817848523380235E-6 | ||
Cyp3a59 Cyp3a59em1(IMPC)Marc |
Hematology | Mean platelet volume | heterozygote | decreased mean platelet volume | 6.044693691364955E-6 | ||
Ces2e Ces2eem1(IMPC)Marc |
Hematology | Platelet count | homozygote | thrombocytopenia | 6.075641067582183E-6 | ||
Usp15 Usp15em1(IMPC)Marc |
Hematology | White blood cell count | homozygote | increased leukocyte cell number | 6.135553576314123E-6 | ||
Cpa1 Cpa1em1(IMPC)Marc |
Hematology | Mean cell volume | homozygote | increased mean corpuscular volume | 6.17778141531744E-6 | ||
Suv39h2 Suv39h2em1(IMPC)Marc |
Clinical Chemistry | Alkaline phosphatase | homozygote | increased circulating alkaline phosphatase level | 6.188343377289129E-6 | ||
Blvrb Blvrbtm1(KOMP)Wtsi |
Echo | LVAWs | homozygote | thin ventricular wall | 6.2696308305021375E-6 | ||
Phf21b Phf21bem1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 6.3450870584347285E-6 | ||
Lhcgr Lhcgrtm1(KOMP)Vlcg |
Hematology | Platelet count | homozygote | thrombocytopenia | 6.480393494712189E-6 | ||
Usp26 Usp26em1(IMPC)Marc |
Open Field | Whole arena average speed | hemizygote | decreased locomotor activity | 6.559599114552839E-6 | ||
Usp26 Usp26em1(IMPC)Marc |
Open Field | Distance travelled - total | hemizygote | decreased locomotor activity | 6.567509444721509E-6 | ||
Ints6l Ints6lem1(IMPC)Marc |
Clinical Chemistry | Phosphorus | homozygote | decreased circulating phosphate level | 6.801918516430305E-6 | ||
Fbxl19 Fbxl19tm1b(EUCOMM)Wtsi |
Hematology | Neutrophil cell count | heterozygote | increased neutrophil cell number | 6.806672899983823E-6 | ||
Trim37 Trim37em1(IMPC)Marc |
Grip Strength | Forelimb grip strength measurement mean | homozygote | increased grip strength | 6.811790171923349E-6 | ||
Blvrb Blvrbtm1(KOMP)Wtsi |
Auditory Brain Stem Response | 30kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 7.111427294148598E-6 | ||
Kdm2b Kdm2bem1(IMPC)Marc |
Hematology | Neutrophil differential count | heterozygote | increased neutrophil cell number | 7.184144124039449E-6 | ||
Fbxw8 Fbxw8tm1b(EUCOMM)Hmgu |
Clinical Chemistry | Urea (Blood Urea Nitrogen - BUN) | heterozygote | increased blood urea nitrogen level | 7.20838852430461E-6 | ||
Fbxo28 Fbxo28em1(IMPC)Mhzh |
Grip Strength | Forelimb grip strength normalised against body weight | heterozygote | increased grip strength | 7.300703146029264E-6 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Open Field | Whole arena resting time | heterozygote | decreased locomotor activity | 7.383223874057876E-6 | ||
Usp15 Usp15em1(IMPC)Marc |
Intraperitoneal glucose tolerance test (IPGTT) | Area under glucose response curve | homozygote | improved glucose tolerance | 7.384734999504872E-6 | ||
Ube2w Ube2wtm1b(EUCOMM)Wtsi |
Grip Strength | Forelimb grip strength normalised against body weight | homozygote | increased grip strength | 7.610381544509437E-6 | ||
Ube2d3 Ube2d3tm1b(EUCOMM)Hmgu |
Open Field | Periphery resting time | heterozygote | decreased locomotor activity | 7.612704393977765E-6 | ||
Ppp2r5e Ppp2r5eem1(IMPC)Marc |
Open Field | Periphery distance travelled | homozygote | decreased locomotor activity | 7.73109513829695E-6 | ||
BC049715 BC049715tm1b(KOMP)Mbp |
Hematology | Hemoglobin | homozygote | decreased hemoglobin content | 7.81190101406537E-6 | ||
Usp45 Usp45em1(IMPC)Marc |
Hematology | Mean cell hemoglobin concentration | homozygote | increased mean corpuscular hemoglobin concentration | 7.861338417569641E-6 | ||
Fbxo10 Fbxo10tm1b(KOMP)Wtsi |
Clinical Chemistry | Phosphorus | homozygote | decreased circulating phosphate level | 7.921938049548771E-6 | ||
Lhcgr Lhcgrtm1(KOMP)Vlcg |
Hematology | Lymphocyte cell count | homozygote | increased lymphocyte cell number | 7.998222827154677E-6 | ||
Hnrnph1 Hnrnph1tm1b(KOMP)Wtsi |
Hematology | Neutrophil differential count | heterozygote | decreased neutrophil cell number | 8.035204700718168E-6 | ||
Chst12 Chst12em1(IMPC)Marc |
Hematology | White blood cell count | homozygote | decreased leukocyte cell number | 8.0445061030332E-6 | ||
Slco6c1 Slco6c1em1(IMPC)Marc |
Open Field | Latency to center entry | homozygote | decreased exploration in new environment | 8.053317287703976E-6 | ||
Dusp7 Dusp7tm1(KOMP)Wtsi |
Acoustic Startle and Pre-pulse Inhibition (PPI) | Response amplitude - S | homozygote | increased startle reflex | 8.116619937936775E-6 | ||
Fbxo38 Fbxo38em2(IMPC)Marc |
Hematology | Mean platelet volume | homozygote | increased mean platelet volume | 8.140509635268245E-6 | ||
Fbxw13 Fbxw13em2(IMPC)Marc |
Hematology | Mean corpuscular hemoglobin | homozygote | increased mean corpuscular hemoglobin | 8.222695214499254E-6 | ||
Phf11a Phf11atm1b(NCOM)Mfgc |
Clinical Chemistry | Triglycerides | heterozygote | increased circulating triglyceride level | 8.244453056249768E-6 | ||
Usp31 Usp31em1(IMPC)Marc |
Grip Strength | Forelimb and hindlimb grip strength measurement mean | homozygote | decreased grip strength | 8.281349437311292E-6 | ||
Cyld Cyldem2(IMPC)Marc |
Open Field | Latency to center entry | homozygote | decreased exploration in new environment | 8.317890205944423E-6 | ||
Etaa1 Etaa1em1(IMPC)Marc |
Hematology | Mean cell hemoglobin concentration | homozygote | decreased mean corpuscular hemoglobin concentration | 8.385663932131138E-6 | ||
Ppp2r5e Ppp2r5eem1(IMPC)Marc |
Open Field | Whole arena average speed | homozygote | decreased locomotor activity | 8.397842975682579E-6 | ||
Prickle4 Prickle4em1(IMPC)Marc |
Open Field | Whole arena resting time | homozygote | decreased locomotor activity | 8.409304427914321E-6 | ||
Fbxl19 Fbxl19tm1b(EUCOMM)Wtsi |
Hematology | Mean platelet volume | heterozygote | increased mean platelet volume | 8.433871698798612E-6 | ||
Prmt6 Prmt6em1(IMPC)Marc |
Clinical Chemistry | Alanine aminotransferase | homozygote | increased circulating alanine transaminase level | 8.528615580871701E-6 | ||
Ints6l Ints6lem1(IMPC)Marc |
Echo | LVAWd | homozygote | decreased heart left ventricle size | 8.581863767176401E-6 | ||
Brix1 Brix1tm1b(KOMP)Mbp |
Acoustic Startle and Pre-pulse Inhibition (PPI) | Response amplitude - S | heterozygote | increased startle reflex | 8.592131052864715E-6 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 8.720015102881007E-6 | ||
Ppp2r5e Ppp2r5eem1(IMPC)Marc |
Hematology | Hematocrit | homozygote | increased hematocrit | 8.745103514229413E-6 | ||
Suv39h2 Suv39h2em1(IMPC)Marc |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | homozygote | increased fasting circulating glucose level | 9.143344868789427E-6 | ||
Fbxo43 Fbxo43em1(IMPC)Marc |
Hematology | Hematocrit | homozygote | increased hematocrit | 9.235328434442636E-6 | ||
Cpa1 Cpa1em1(IMPC)Marc |
Hematology | White blood cell count | homozygote | increased leukocyte cell number | 9.34602849156363E-6 | ||
Aars2 Aars2tm1(KOMP)Wtsi |
Hematology | Red blood cell distribution width | heterozygote | decreased red blood cell distribution width | 9.37703407544177E-6 | ||
Ankle1 Ankle1tm1(KOMP)Wtsi |
Open Field | Whole arena resting time | homozygote | decreased locomotor activity | 9.570847396389581E-6 | ||
Fbxo38 Fbxo38em2(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 9.672585292719305E-6 | ||
Slco6c1 Slco6c1em1(IMPC)Marc |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | homozygote | increased fasting circulating glucose level | 9.682844392955303E-6 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Clinical Chemistry | Albumin | heterozygote | decreased circulating serum albumin level | 9.747305739438161E-6 | ||
Phf3 Phf3em2(IMPC)Marc |
Auditory Brain Stem Response | 24kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 9.78074149315944E-6 | ||
Usp31 Usp31em1(IMPC)Marc |
Clinical Chemistry | Phosphorus | homozygote | increased circulating phosphate level | 9.833633157541044E-6 | ||
Hnrnpd Hnrnpdtm1b(KOMP)Wtsi |
Hematology | White blood cell count | heterozygote | decreased leukocyte cell number | 9.887345186143648E-6 | ||
Gsdmd Gsdmdem1(IMPC)Marc |
Echo | LVIDs | homozygote | dilated heart left ventricle | 9.900231816573068E-6 | ||
Bola2 Bola2tm1(KOMP)Wtsi |
Hematology | Hemoglobin | homozygote | decreased hemoglobin content | 9.923070138029289E-6 | ||
Gsdmd Gsdmdem1(IMPC)Marc |
Echo | LVPWs | homozygote | decreased heart left ventricle size | 9.93573121377267E-6 | ||
Fancl Fancltm1b(EUCOMM)Hmgu |
Combined SHIRPA and Dysmorphology | Coat - color pattern - head | homozygote | abnormal coat/hair pigmentation | 9.986470104195178E-6 | ||
Fancl Fancltm1b(EUCOMM)Hmgu |
Combined SHIRPA and Dysmorphology | Coat - color pattern - back | homozygote | abnormal coat/hair pigmentation | 9.986470104195178E-6 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Grip Strength | Forelimb and hindlimb grip strength measurement mean | homozygote | decreased grip strength | 1.0010584446717985E-5 | ||
Htr2b Htr2btm1b(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | Fat mass | heterozygote | increased total body fat amount | 1.0058513908006717E-5 | ||
Eddm3b Eddm3btm1b(KOMP)Wtsi |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 1.0060050954052713E-5 | ||
Fancl Fancltm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | Lean/Body weight | homozygote | decreased lean body mass | 1.0193345588049851E-5 | ||
Acsm1 Acsm1em1(IMPC)Mhzh |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 1.0251559615426231E-5 | ||
Ppp2r2a Ppp2r2atm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Lean mass | heterozygote | decreased lean body mass | 1.0306624062650371E-5 | ||
Fbxo38 Fbxo38em2(IMPC)Marc |
Hematology | Lymphocyte cell count | homozygote | increased lymphocyte cell number | 1.0381369065726176E-5 | ||
Dbil5 Dbil5tm1(KOMP)Wtsi |
Clinical Chemistry | Total protein | homozygote | increased circulating total protein level | 1.0673926226445474E-5 | ||
Fbxo38 Fbxo38em2(IMPC)Marc |
Hematology | White blood cell count | homozygote | increased leukocyte cell number | 1.0869692232517991E-5 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Eye Morphology | Corneal opacity | heterozygote | corneal opacity | 1.092221191356657E-5 | ||
Itprid1 Itprid1em1(IMPC)Marc |
Hematology | Neutrophil differential count | homozygote | increased neutrophil cell number | 1.12532597995596E-5 | ||
Ezh1 Ezh1tm1b(EUCOMM)Wtsi |
Hematology | Red blood cell count | homozygote | decreased erythrocyte cell number | 1.1353967238392215E-5 | ||
Phf21b Phf21bem1(IMPC)Marc |
Echo | LVAWs | homozygote | thin ventricular wall | 1.1522873137437273E-5 | ||
Tsg101 Tsg101tm1b(EUCOMM)Hmgu |
Open Field | Whole arena resting time | heterozygote | decreased locomotor activity | 1.1652972716547083E-5 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | Mean platelet volume | homozygote | increased mean platelet volume | 1.1686312063829973E-5 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Open Field | Whole arena resting time | heterozygote | decreased locomotor activity | 1.1910716239071917E-5 | ||
Fbxo38 Fbxo38em2(IMPC)Marc |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | homozygote | decreased bone mineral density | 1.192250147141749E-5 | ||
Aars2 Aars2tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Vocalization | heterozygote | abnormal vocalization | 1.1955808076891117E-5 | ||
Ppp2r5d Ppp2r5dem2(IMPC)Marc |
Combined SHIRPA and Dysmorphology | Vocalization | homozygote | abnormal vocalization | 1.1955808076891117E-5 | ||
Fbxo38 Fbxo38em2(IMPC)Marc |
Hematology | Lymphocyte cell count | homozygote | increased lymphocyte cell number | 1.2098003935534507E-5 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Clinical Chemistry | Urea (Blood Urea Nitrogen - BUN) | homozygote | increased blood urea nitrogen level | 1.2098894330847543E-5 | ||
Erich2 Erich2em1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 1.22241444842075E-5 | ||
Emc4 Emc4tm1(KOMP)Wtsi |
Hematology | Eosinophil cell count | heterozygote | increased eosinophil cell number | 1.2237772352818865E-5 | ||
Fbxl2 Fbxl2em2(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 1.2479657925723586E-5 | ||
Trim37 Trim37em1(IMPC)Marc |
Hematology | Red blood cell distribution width | homozygote | decreased red blood cell distribution width | 1.2496116141846869E-5 | ||
Atg4a Atg4aem2(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 1.2560487448354252E-5 | ||
Hilpda Hilpdaem1(IMPC)Mhzh |
Echo | Ejection Fraction | homozygote | decreased cardiac muscle contractility | 1.262663136003539E-5 | ||
Ppp2r1b Ppp2r1btm1b(EUCOMM)Wtsi |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | homozygote | increased fasting circulating glucose level | 1.2770943612849806E-5 | ||
Cpa1 Cpa1em1(IMPC)Marc |
Hematology | Red blood cell distribution width | homozygote | decreased red blood cell distribution width | 1.3135027984390035E-5 | ||
Ints6l Ints6lem1(IMPC)Marc |
Hematology | Red blood cell distribution width | hemizygote | decreased red blood cell distribution width | 1.330380382569274E-5 | ||
Hnrnpd Hnrnpdtm1b(KOMP)Wtsi |
Open Field | Center distance travelled | heterozygote | decreased locomotor activity | 1.338689344265731E-5 | ||
Kdm2b Kdm2bem1(IMPC)Marc |
Hematology | Lymphocyte differential count | heterozygote | decreased lymphocyte cell number | 1.3622884580399841E-5 | ||
Lsm14a Lsm14atm1b(KOMP)Wtsi |
Auditory Brain Stem Response | 30kHz-evoked ABR Threshold | heterozygote | abnormal auditory brainstem response | 1.3701953321287874E-5 | ||
Ces1f Ces1ftm1b(KOMP)Wtsi |
Auditory Brain Stem Response | 30kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 1.3701953321287874E-5 | ||
Otud6a Otud6atm1(KOMP)Vlcg |
Clinical Chemistry | Total cholesterol | homozygote | increased circulating cholesterol level | 1.374715066049248E-5 | ||
Fbxo36 Fbxo36tm1b(KOMP)Wtsi |
Grip Strength | Forelimb and hindlimb grip strength normalised against body weight | homozygote | decreased grip strength | 1.3914501323597506E-5 | ||
Lypd2 Lypd2em1(IMPC)Marc |
Hematology | Mean platelet volume | homozygote | decreased mean platelet volume | 1.412885103491135E-5 | ||
Prickle4 Prickle4em1(IMPC)Marc |
Open Field | Latency to center entry | homozygote | decreased exploration in new environment | 1.416444774804404E-5 | ||
Ppp1r14d Ppp1r14dtm1b(KOMP)Wtsi |
Hematology | Red blood cell distribution width | homozygote | decreased red blood cell distribution width | 1.4236026800062973E-5 | ||
Otud6a Otud6atm1(KOMP)Vlcg |
Open Field | Periphery distance travelled | homozygote | hyperactivity | 1.4246262253436726E-5 | ||
Ins1 Ins1em1(IMPC)Marc |
Echo | LVAWs | homozygote | thin ventricular wall | 1.4416070371225942E-5 | ||
Ppp1r14d Ppp1r14dtm1b(KOMP)Wtsi |
Echo | LVIDs | homozygote | dilated heart left ventricle | 1.4674061276309658E-5 | ||
Fbxo2 Fbxo2tm1b(EUCOMM)Wtsi |
Open Field | Whole arena resting time | homozygote | decreased locomotor activity | 1.477940531913191E-5 | ||
Atg4b Atg4bem1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 1.4790307432122063E-5 | ||
Atg4d Atg4dem1(IMPC)Marc |
Echo | LVIDs | homozygote | dilated heart left ventricle | 1.5067368622112554E-5 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Body Composition (DEXA lean/fat) | Fat/Body weight | homozygote | increased total body fat amount | 1.5248348972818349E-5 | ||
Psmd14 Psmd14tm1b(NCOM)Cmhd |
Heart Weight | Heart weight | heterozygote | increased heart weight | 1.543665894132573E-5 | ||
Dusp7 Dusp7tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Coat - color - head | homozygote | abnormal coat/hair pigmentation | 1.5713178072473966E-5 | ||
Ankle1 Ankle1tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Coat - color - head | homozygote | abnormal coat/hair pigmentation | 1.5713178072473966E-5 | ||
Ppp2r2a Ppp2r2atm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | heterozygote | decreased bone mineral density | 1.580177377036307E-5 | ||
Phf21b Phf21bem1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 1.5996651200111955E-5 | ||
Usp39 Usp39tm1b(EUCOMM)Hmgu |
Combined SHIRPA and Dysmorphology | Coat - color - back | heterozygote | abnormal coat/hair pigmentation | 1.6036899978644215E-5 | ||
Emc4 Emc4tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Coat - color - back | heterozygote | abnormal coat/hair pigmentation | 1.6036899978644215E-5 | ||
Ankle1 Ankle1tm1(KOMP)Wtsi |
Open Field | Periphery resting time | homozygote | decreased locomotor activity | 1.6113237506942824E-5 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Eye Morphology | Pupil Shape | heterozygote | irregularly shaped pupil | 1.6151851014001295E-5 | ||
Vav2 Vav2em1(IMPC)Marc |
Echo | LVPWd | homozygote | thin ventricular wall | 1.6176383724086918E-5 | ||
Ctsm Ctsmtm1(KOMP)Wtsi |
Hematology | Monocyte cell count | homozygote | increased monocyte cell number | 1.634360341995489E-5 | ||
Ppp2r5e Ppp2r5eem1(IMPC)Marc |
Combined SHIRPA and Dysmorphology | Activity (body position) | homozygote | abnormal locomotor behavior | 1.6887257515918463E-5 | ||
Usp50 Usp50tm1(KOMP)Vlcg |
Eye Morphology | Pupil Shape | heterozygote | irregularly shaped pupil | 1.701610381132923E-5 | ||
Otud6a Otud6atm1(KOMP)Vlcg |
Clinical Chemistry | HDL-cholesterol | homozygote | increased circulating HDL cholesterol level | 1.7451453459216282E-5 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Hematology | Neutrophil cell count | heterozygote | increased neutrophil cell number | 1.749792863847688E-5 | ||
Bap1 Bap1em2(IMPC)Marc |
Body Composition (DEXA lean/fat) | Bone Area | heterozygote | abnormal bone structure | 1.7514628780190833E-5 | ||
Ces2e Ces2eem1(IMPC)Marc |
Hematology | Hematocrit | homozygote | decreased hematocrit | 1.7564401787240058E-5 | ||
Bbof1 Bbof1em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 1.7572765500517562E-5 | ||
Ube2d3 Ube2d3tm1b(EUCOMM)Hmgu |
Open Field | Whole arena resting time | heterozygote | decreased locomotor activity | 1.7584939996595494E-5 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Open Field | Periphery average speed | heterozygote | decreased locomotor activity | 1.7686326827970333E-5 | ||
Fbxl2 Fbxl2em2(IMPC)Marc |
Hematology | Hematocrit | homozygote | increased hematocrit | 1.8007423932431266E-5 | ||
Fancl Fancltm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | Lean mass | homozygote | decreased lean body mass | 1.80368879227899E-5 | ||
Ints6l Ints6lem1(IMPC)Marc |
Open Field | Latency to center entry | hemizygote | decreased exploration in new environment | 1.804816201911308E-5 | ||
Ctu2 Ctu2tm1(KOMP)Wtsi |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 1.8269442080054432E-5 | ||
Fbxl15 Fbxl15em1(IMPC)Marc |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | homozygote | increased fasting circulating glucose level | 1.8316854038857855E-5 | ||
Lmo7 Lmo7em1(IMPC)Marc |
Clinical Chemistry | Creatinine | homozygote | increased circulating creatinine level | 1.850862281571608E-5 | ||
Esr2 Esr2em1(IMPC)Marc |
Echo | LVPWd | homozygote | thin ventricular wall | 1.8653272491064854E-5 | ||
Aars2 Aars2tm1(KOMP)Wtsi |
Hematology | Neutrophil cell count | heterozygote | increased neutrophil cell number | 1.8738792277872562E-5 | ||
Uchl5 Uchl5tm1(NCOM)Mfgc |
Open Field | Periphery distance travelled | heterozygote | decreased locomotor activity | 1.8741713574854657E-5 | ||
Htr4 Htr4em2(IMPC)Marc |
Hematology | Mean cell volume | homozygote | increased mean corpuscular volume | 1.9005019566975534E-5 | ||
Kdm2b Kdm2bem1(IMPC)Marc |
Echo | LVAWd | heterozygote | decreased heart left ventricle size | 1.9308001355966553E-5 | ||
Ces2f Ces2ftm1b(KOMP)Wtsi |
Hematology | Platelet count | homozygote | thrombocytosis | 1.935009640874341E-5 | ||
Fbxo36 Fbxo36tm1b(KOMP)Wtsi |
Hematology | Neutrophil differential count | homozygote | increased neutrophil cell number | 1.9366565538803115E-5 | ||
Dusp7 Dusp7tm1(KOMP)Wtsi |
Echo | LVIDd | homozygote | dilated heart left ventricle | 1.947710188687779E-5 | ||
Trim37 Trim37em1(IMPC)Marc |
Echo | LVPWs | homozygote | decreased heart left ventricle size | 1.9553090169210918E-5 | ||
Dusp7 Dusp7tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Coat - color - abdomen | homozygote | abnormal coat/hair pigmentation | 1.9569177311495878E-5 | ||
Ankle1 Ankle1tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Coat - color - abdomen | homozygote | abnormal coat/hair pigmentation | 1.9569177311495878E-5 | ||
Alg1 Alg1tm1b(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Coat - color - abdomen | heterozygote | abnormal coat/hair pigmentation | 1.9569177311495878E-5 | ||
Fbxo22 Fbxo22tm1b(EUCOMM)Wtsi |
Acoustic Startle and Pre-pulse Inhibition (PPI) | % Pre-pulse inhibition - PPI2 | homozygote | decreased prepulse inhibition | 1.9631779650808312E-5 | ||
Prxl2a Prxl2aem1(IMPC)Marc |
Echo | LVPWd | homozygote | thin ventricular wall | 1.9652214177767746E-5 | ||
Fbxo36 Fbxo36tm1b(KOMP)Wtsi |
Hematology | Red blood cell distribution width | homozygote | increased red blood cell distribution width | 1.967729622265324E-5 | ||
Hilpda Hilpdaem1(IMPC)Mhzh |
Echo | LVPWd | homozygote | thin ventricular wall | 1.9962362785008736E-5 | ||
Snx25 Snx25tm1b(KOMP)Wtsi |
Echo | LVIDs | heterozygote | dilated heart left ventricle | 2.0057168512721546E-5 | ||
Rbm11 Rbm11em1(IMPC)Marc |
Echo | LVPWd | homozygote | thin ventricular wall | 2.0121649868087843E-5 | ||
Abhd3 Abhd3em1(IMPC)Marc |
Open Field | Latency to center entry | homozygote | decreased exploration in new environment | 2.0245652194716968E-5 | ||
Ins1 Ins1em1(IMPC)Marc |
Grip Strength | Forelimb and hindlimb grip strength measurement mean | homozygote | decreased grip strength | 2.059483631455805E-5 | ||
Atg4c Atg4cem2(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 2.0628664060495794E-5 | ||
Fbxo24 Fbxo24em2(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 2.0705761926365085E-5 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Open Field | Percentage center movement time | heterozygote | increased anxiety-related response | 2.0732288248836994E-5 | ||
Ppp1cc Ppp1cctm1b(EUCOMM)Wtsi |
Open Field | Periphery resting time | homozygote | decreased locomotor activity | 2.1171306798350997E-5 | ||
Hnrnpr Hnrnprem1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 2.1191608539083973E-5 | ||
Kmt2a Kmt2aem1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | heterozygote | decreased bone mineral density | 2.131239671143703E-5 | ||
Fbxl2 Fbxl2em2(IMPC)Marc |
Hematology | Hemoglobin | homozygote | increased hemoglobin content | 2.13465464184992E-5 | ||
Acsm1 Acsm1em1(IMPC)Mhzh |
Open Field | Latency to center entry | homozygote | decreased exploration in new environment | 2.138186027877964E-5 | ||
Esr2 Esr2em1(IMPC)Marc |
Hematology | White blood cell count | homozygote | decreased leukocyte cell number | 2.140650940418709E-5 | ||
Cntn3 Cntn3em1(IMPC)Marc |
Clinical Chemistry | Urea (Blood Urea Nitrogen - BUN) | homozygote | increased blood urea nitrogen level | 2.1442405341076665E-5 | ||
Ube2z Ube2zem1(IMPC)Marc |
Echo | LVAWd | heterozygote | decreased heart left ventricle size | 2.180420960939955E-5 | ||
Ufm1 Ufm1em1(IMPC)Marc |
Hematology | Red blood cell distribution width | heterozygote | decreased red blood cell distribution width | 2.207359102612827E-5 | ||
Acsm1 Acsm1em1(IMPC)Mhzh |
Echo | LVAWs | homozygote | thin ventricular wall | 2.2139534848975018E-5 | ||
Ube2e1 Ube2e1em1(IMPC)Marc |
Hematology | Mean platelet volume | homozygote | increased mean platelet volume | 2.2274551156442612E-5 | ||
B3galt1 B3galt1em1(IMPC)Marc |
Open Field | Number of center entries | homozygote | decreased locomotor activity | 2.2338717826642096E-5 | ||
Cnpy1 Cnpy1tm1(KOMP)Wtsi |
Clinical Chemistry | Albumin | homozygote | decreased circulating serum albumin level | 2.2363565221894532E-5 | ||
Fshr Fshrtm1(KOMP)Vlcg |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | homozygote | decreased bone mineral density | 2.3048176444717683E-5 | ||
Fancl Fancltm1b(EUCOMM)Hmgu |
Combined SHIRPA and Dysmorphology | Coat - color - back | homozygote | abnormal coat/hair pigmentation | 2.3157106625149027E-5 | ||
Prmt6 Prmt6em1(IMPC)Marc |
Echo | LVAWd | homozygote | decreased heart left ventricle size | 2.3283546397578903E-5 | ||
Ube2w Ube2wtm1b(EUCOMM)Wtsi |
Grip Strength | Forelimb grip strength normalised against body weight | homozygote | increased grip strength | 2.390448389633093E-5 | ||
Abhd3 Abhd3em1(IMPC)Marc |
Echo | Ejection Fraction | homozygote | decreased cardiac muscle contractility | 2.402983227511868E-5 | ||
Fbxo2 Fbxo2tm1b(EUCOMM)Wtsi |
Acoustic Startle and Pre-pulse Inhibition (PPI) | Response amplitude - S | homozygote | decreased startle reflex | 2.4071880034171045E-5 | ||
Hnrnpd Hnrnpdtm1b(KOMP)Wtsi |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 2.4164952264982276E-5 | ||
Bola2 Bola2tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Coat - color - head | homozygote | abnormal coat/hair pigmentation | 2.4177479645004496E-5 | ||
Ube2d3 Ube2d3tm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | Lean/Body weight | heterozygote | decreased lean body mass | 2.4268687411677092E-5 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Eye Morphology | Pupil Light Response | heterozygote | impaired pupillary reflex | 2.462906195432879E-5 | ||
Usp46 Usp46em1(IMPC)Marc |
Clinical Chemistry | Triglycerides | homozygote | increased circulating triglyceride level | 2.4725593902985565E-5 | ||
Bod1 Bod1tm1b(KOMP)Wtsi |
Heart Weight | Heart weight | heterozygote | increased heart weight | 2.4974906409624964E-5 | ||
Usp46 Usp46em1(IMPC)Marc |
Clinical Chemistry | Total cholesterol | homozygote | increased circulating cholesterol level | 2.52102327067405E-5 | ||
Trim37 Trim37em1(IMPC)Marc |
Echo | LVPWd | homozygote | thin ventricular wall | 2.526803655200638E-5 | ||
Suv39h2 Suv39h2em1(IMPC)Marc |
Grip Strength | Forelimb and hindlimb grip strength normalised against body weight | homozygote | increased grip strength | 2.5350676878588274E-5 | ||
Uchl5 Uchl5tm1(NCOM)Mfgc |
Open Field | Periphery resting time | heterozygote | decreased locomotor activity | 2.5356879632454365E-5 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Open Field | Whole arena average speed | heterozygote | decreased locomotor activity | 2.558185406087432E-5 | ||
Ufm1 Ufm1em1(IMPC)Marc |
Echo | LVIDs | heterozygote | dilated heart left ventricle | 2.5583394744899124E-5 | ||
Blvrb Blvrbtm1(KOMP)Wtsi |
Auditory Brain Stem Response | 24kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 2.5789206119952723E-5 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Body Composition (DEXA lean/fat) | Lean/Body weight | homozygote | increased lean body mass | 2.6291238100384362E-5 | ||
Kdm1a Kdm1atm1(NCOM)Mfgc |
Grip Strength | Forelimb and hindlimb grip strength measurement mean | heterozygote | decreased grip strength | 2.6301057005184703E-5 | ||
Ces2e Ces2eem1(IMPC)Marc |
Hematology | Hemoglobin | homozygote | decreased hemoglobin content | 2.6855261239688843E-5 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Combined SHIRPA and Dysmorphology | Locomotor activity | heterozygote | decreased exploration in new environment | 2.700801269384101E-5 | ||
Fancl Fancltm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | Body length | homozygote | decreased body length | 2.7030213459511288E-5 | ||
Sorcs2 Sorcs2em1(IMPC)Marc |
Open Field | Center resting time | homozygote | decreased locomotor activity | 2.7037158361054026E-5 | ||
Atg4c Atg4cem2(IMPC)Marc |
Heart Weight | Heart weight | homozygote | increased heart weight | 2.7385945941205136E-5 | ||
Hnrnph1 Hnrnph1tm1b(KOMP)Wtsi |
Hematology | Mean platelet volume | heterozygote | increased mean platelet volume | 2.7426471206126735E-5 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Clinical Chemistry | HDL-cholesterol | homozygote | increased circulating HDL cholesterol level | 2.765271347016096E-5 | ||
Usp45 Usp45em1(IMPC)Marc |
Hematology | Monocyte cell count | homozygote | increased monocyte cell number | 2.78704465017654E-5 | ||
Dagla Daglatm1a(EUCOMM)Wtsi |
Open Field | Periphery permanence time | homozygote | decreased thigmotaxis | 2.7998767109238543E-5 | ||
Hnrnpd Hnrnpdtm1b(KOMP)Wtsi |
Hematology | Eosinophil cell count | heterozygote | increased eosinophil cell number | 2.8702776035061106E-5 | ||
Fbxo10 Fbxo10tm1b(KOMP)Wtsi |
Hematology | Neutrophil differential count | homozygote | decreased neutrophil cell number | 2.8924339858349413E-5 | ||
Dagla Daglatm1a(EUCOMM)Wtsi |
Open Field | Center permanence time | homozygote | decreased thigmotaxis | 2.894242606998887E-5 | ||
Dagla Daglatm1a(EUCOMM)Wtsi |
Open Field | Percentage center time | homozygote | abnormal behavior | 2.8972111977054738E-5 | ||
Fshr Fshrtm1(KOMP)Vlcg |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | homozygote | increased fasting circulating glucose level | 2.8973669031984173E-5 | ||
Carm1 Carm1tm1b(EUCOMM)Hmgu |
Hematology | Lymphocyte cell count | heterozygote | decreased lymphocyte cell number | 2.9056529456283897E-5 | ||
Kmt2a Kmt2aem1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Lean/Body weight | heterozygote | increased lean body mass | 2.925129228970036E-5 | ||
Esr2 Esr2em1(IMPC)Marc |
Clinical Chemistry | Albumin | homozygote | increased circulating serum albumin level | 2.985830360557884E-5 | ||
Phf5a Phf5aem2(IMPC)Marc |
Body Composition (DEXA lean/fat) | Fat/Body weight | heterozygote | decreased total body fat amount | 3.015388938365504E-5 | ||
Mir204 Mir204tm1Wtsi |
Eye Morphology | Lens Opacity | homozygote | cataract | 3.0354507543961518E-5 | ||
Ppp2r5e Ppp2r5eem1(IMPC)Marc |
Open Field | Periphery average speed | homozygote | decreased locomotor activity | 3.042813295905944E-5 | ||
Fbxo27 Fbxo27em2(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 3.060934250243008E-5 | ||
Vav2 Vav2em1(IMPC)Marc |
Echo | LVAWd | homozygote | decreased heart left ventricle size | 3.066917270189151E-5 | ||
Fbxo38 Fbxo38em2(IMPC)Marc |
Echo | HR | homozygote | increased heart rate | 3.083041883655824E-5 | ||
Cimip2b Cimip2btm1(KOMP)Wtsi |
Clinical Chemistry | Urea (Blood Urea Nitrogen - BUN) | homozygote | increased blood urea nitrogen level | 3.087299410253763E-5 | ||
Phf21b Phf21bem1(IMPC)Marc |
Echo | LVAWd | homozygote | decreased heart left ventricle size | 3.093278064625338E-5 | ||
Atg4b Atg4bem1(IMPC)Marc |
Clinical Chemistry | Total protein | homozygote | decreased circulating total protein level | 3.104930874542333E-5 | ||
Bola2 Bola2tm1(KOMP)Wtsi |
Clinical Chemistry | Iron | homozygote | decreased circulating iron level | 3.106024814769626E-5 | ||
Tmigd1 Tmigd1em1(IMPC)Marc |
Clinical Chemistry | Urea (Blood Urea Nitrogen - BUN) | homozygote | increased blood urea nitrogen level | 3.111377009190619E-5 | ||
Cox8a Cox8aem1(IMPC)Marc |
Open Field | Center distance travelled | homozygote | decreased locomotor activity | 3.127333548036404E-5 | ||
Hnrnpr Hnrnprem1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 3.128179014311172E-5 | ||
Htr2b Htr2btm1b(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | Lean/Body weight | heterozygote | decreased lean body mass | 3.133670907118358E-5 | ||
Emc4 Emc4tm1(KOMP)Wtsi |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | heterozygote | increased fasting circulating glucose level | 3.178541737725027E-5 | ||
Bola2 Bola2tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Coat - color - abdomen | homozygote | abnormal coat/hair pigmentation | 3.179077248205431E-5 | ||
Ezh1 Ezh1tm1b(EUCOMM)Wtsi |
Hematology | Hematocrit | homozygote | decreased hematocrit | 3.1949279218679294E-5 | ||
Ppp1r14a Ppp1r14aem1(IMPC)Marc |
Hematology | Monocyte cell count | homozygote | increased monocyte cell number | 3.233133247704245E-5 | ||
Atp13a5 Atp13a5em1(IMPC)Marc |
Grip Strength | Forelimb and hindlimb grip strength measurement mean | homozygote | increased grip strength | 3.286396895418875E-5 | ||
Phf5a Phf5aem2(IMPC)Marc |
Hematology | Red blood cell distribution width | heterozygote | increased red blood cell distribution width | 3.3102660381700844E-5 | ||
Fbxl19 Fbxl19tm1b(EUCOMM)Wtsi |
Hematology | White blood cell count | heterozygote | increased leukocyte cell number | 3.323330747662112E-5 | ||
Ints6l Ints6lem1(IMPC)Marc |
Hematology | Red blood cell distribution width | homozygote | decreased red blood cell distribution width | 3.351651321281679E-5 | ||
Usp16 Usp16tm1b(EUCOMM)Hmgu |
Hematology | Eosinophil differential count | heterozygote | increased eosinophil cell number | 3.403360824449919E-5 | ||
Alg1 Alg1tm1b(KOMP)Wtsi |
Hematology | Lymphocyte cell count | heterozygote | increased lymphocyte cell number | 3.414096136111766E-5 | ||
Suv39h2 Suv39h2em1(IMPC)Marc |
Hematology | Mean cell hemoglobin concentration | homozygote | decreased mean corpuscular hemoglobin concentration | 3.441489388933405E-5 | ||
Usp26 Usp26em1(IMPC)Marc |
Clinical Chemistry | Triglycerides | homozygote | increased circulating triglyceride level | 3.485351408016868E-5 | ||
Cntn3 Cntn3em1(IMPC)Marc |
Clinical Chemistry | Triglycerides | homozygote | increased circulating triglyceride level | 3.5147932067047805E-5 | ||
Ppp2r5e Ppp2r5eem1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Bone Area | homozygote | abnormal bone structure | 3.532788105076179E-5 | ||
Chst12 Chst12em1(IMPC)Marc |
Acoustic Startle and Pre-pulse Inhibition (PPI) | Response amplitude - S | homozygote | increased startle reflex | 3.597177055780776E-5 | ||
Fbxo2 Fbxo2tm1b(EUCOMM)Wtsi |
Clinical Chemistry | Glucose | homozygote | increased circulating glucose level | 3.637306144810282E-5 | ||
Kdm2b Kdm2bem1(IMPC)Marc |
Clinical Chemistry | Phosphorus | heterozygote | decreased circulating phosphate level | 3.686350828502327E-5 | ||
Arel1 Arel1tm1b(EUCOMM)Hmgu |
Open Field | Periphery average speed | homozygote | hyperactivity | 3.745317007997073E-5 | ||
Trim37 Trim37em1(IMPC)Marc |
Hematology | Mean platelet volume | homozygote | decreased mean platelet volume | 3.800898412009701E-5 | ||
B3galt1 B3galt1em1(IMPC)Marc |
Open Field | Periphery resting time | homozygote | decreased locomotor activity | 3.8018511986592785E-5 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Eye Morphology | Iris/Pupil | heterozygote | abnormal iris morphology | 3.804771404247731E-5 | ||
Cyld Cyldem2(IMPC)Marc |
Open Field | Center distance travelled | homozygote | decreased locomotor activity | 3.827538603218272E-5 | ||
Fbxl18 Fbxl18tm1b(EUCOMM)Hmgu |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 3.840684803435579E-5 | ||
Fbxo36 Fbxo36tm1b(KOMP)Wtsi |
Hematology | Monocyte cell count | homozygote | decreased monocyte cell number | 3.845714309136383E-5 | ||
Ube2d3 Ube2d3tm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | heterozygote | decreased bone mineral density | 3.846599065582268E-5 | ||
Ppp1r14a Ppp1r14aem1(IMPC)Marc |
Hematology | Lymphocyte cell count | homozygote | increased lymphocyte cell number | 3.846761319437064E-5 | ||
Hnrnph1 Hnrnph1tm1b(KOMP)Wtsi |
Hematology | Lymphocyte differential count | heterozygote | increased lymphocyte cell number | 3.8876827602507547E-5 | ||
Fbxo36 Fbxo36tm1b(KOMP)Wtsi |
Hematology | Platelet count | homozygote | thrombocytopenia | 3.9332997403107584E-5 | ||
Prmt6 Prmt6em1(IMPC)Marc |
Clinical Chemistry | Creatinine | homozygote | increased circulating creatinine level | 3.937279689125717E-5 | ||
Usp26 Usp26em1(IMPC)Marc |
Hematology | Basophil cell count | homozygote | increased basophil cell number | 3.982709677075036E-5 | ||
Phf11a Phf11atm1b(NCOM)Mfgc |
Hematology | Basophil cell count | heterozygote | increased basophil cell number | 3.9831942558521405E-5 | ||
Dlgap2 Dlgap2em1(IMPC)Mhzh |
Open Field | Distance travelled - total | homozygote | decreased locomotor activity | 4.002971400041133E-5 | ||
Chchd5 Chchd5em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Lean mass | heterozygote | increased lean body mass | 4.0058166632661596E-5 | ||
Ppp2r5e Ppp2r5eem1(IMPC)Marc |
Body Composition (DEXA lean/fat) | BMC/Body weight | homozygote | decreased bone mineral content | 4.010664270026609E-5 | ||
Herc4 Herc4tm1b(KOMP)Wtsi |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 4.019907282781787E-5 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Clinical Chemistry | Creatinine | heterozygote | decreased circulating creatinine level | 4.091069058631547E-5 | ||
Htr4 Htr4em2(IMPC)Marc |
Eye Morphology | Pupil Light Response | homozygote | impaired pupillary reflex | 4.09969907195773E-5 | ||
Ppp1r14a Ppp1r14aem1(IMPC)Marc |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | homozygote | increased fasting circulating glucose level | 4.103274113731459E-5 | ||
Hectd4 Hectd4em1(IMPC)Marc |
Clinical Chemistry | Alanine aminotransferase | heterozygote | increased circulating alanine transaminase level | 4.104883555555716E-5 | ||
Fbxl18 Fbxl18tm1b(EUCOMM)Hmgu |
Eye Morphology | Cornea | homozygote | abnormal cornea morphology | 4.193471613689326E-5 | ||
Bola2 Bola2tm1(KOMP)Wtsi |
Intraperitoneal glucose tolerance test (IPGTT) | Initial response to glucose challenge | homozygote | improved glucose tolerance | 4.2634135752450675E-5 | ||
Blvrb Blvrbtm1(KOMP)Wtsi |
Clinical Chemistry | Creatinine | homozygote | increased circulating creatinine level | 4.3148931581526995E-5 | ||
Usp45 Usp45em1(IMPC)Marc |
Hematology | Mean corpuscular hemoglobin | homozygote | increased mean corpuscular hemoglobin | 4.327127680880949E-5 | ||
Atg4d Atg4dem1(IMPC)Marc |
Open Field | Percentage center movement time | homozygote | increased anxiety-related response | 4.399787212605588E-5 | ||
Bbc3 Bbc3em1(IMPC)Marc |
Open Field | Whole arena average speed | homozygote | hyperactivity | 4.407595406519249E-5 | ||
Usp16 Usp16tm1b(EUCOMM)Hmgu |
Hematology | Mean platelet volume | heterozygote | decreased mean platelet volume | 4.427748717716895E-5 | ||
Hnrnpd Hnrnpdtm1b(KOMP)Wtsi |
Open Field | Percentage center time | heterozygote | abnormal behavior | 4.475734749576077E-5 | ||
Hnrnpd Hnrnpdtm1b(KOMP)Wtsi |
Open Field | Center permanence time | heterozygote | increased thigmotaxis | 4.4762480683857575E-5 | ||
Alg1 Alg1tm1b(KOMP)Wtsi |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 4.4972617615712807E-5 | ||
Hnrnpd Hnrnpdtm1b(KOMP)Wtsi |
Open Field | Periphery permanence time | heterozygote | increased thigmotaxis | 4.498858834267594E-5 | ||
Cox8a Cox8aem1(IMPC)Marc |
Clinical Chemistry | Phosphorus | homozygote | decreased circulating phosphate level | 4.504831667873077E-5 | ||
Ash1l Ash1ltm2b(EUCOMM)Hmgu |
Grip Strength | Forelimb grip strength normalised against body weight | heterozygote | increased grip strength | 4.510891085374169E-5 | ||
Hnrnpm Hnrnpmem1(IMPC)Marc |
Echo | HR | heterozygote | increased heart rate | 4.53756692877505E-5 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Open Field | Periphery average speed | homozygote | decreased locomotor activity | 4.564999107969925E-5 | ||
Vav2 Vav2em1(IMPC)Marc |
Open Field | Center distance travelled | homozygote | hyperactivity | 4.594353595166467E-5 | ||
BC049715 BC049715tm1b(KOMP)Mbp |
Hematology | Hematocrit | homozygote | decreased hematocrit | 4.706866093329154E-5 | ||
Speg Spegtm1b(KOMP)Wtsi |
Hematology | Basophil differential count | heterozygote | increased basophil cell number | 4.7114575863815844E-5 | ||
Prmt6 Prmt6em1(IMPC)Marc |
Clinical Chemistry | Aspartate aminotransferase | homozygote | increased circulating aspartate transaminase level | 4.72136125608813E-5 | ||
Usp31 Usp31em1(IMPC)Marc |
Acoustic Startle and Pre-pulse Inhibition (PPI) | % Pre-pulse inhibition - PPI2 | homozygote | increased prepulse inhibition | 4.724495011032559E-5 | ||
Pfkfb2 Pfkfb2tm1b(KOMP)Wtsi |
Hematology | Lymphocyte differential count | homozygote | increased lymphocyte cell number | 4.727742270915769E-5 | ||
Bbc3 Bbc3em1(IMPC)Marc |
Open Field | Number of center entries | homozygote | hyperactivity | 4.7288798668887466E-5 | ||
Usp32 Usp32em1(IMPC)Mhzh |
Hematology | Neutrophil differential count | heterozygote | decreased neutrophil cell number | 4.806851939065382E-5 | ||
Fbxo38 Fbxo38em2(IMPC)Marc |
Clinical Chemistry | Alanine aminotransferase | homozygote | increased circulating alanine transaminase level | 4.8221398174064234E-5 | ||
Apbb3 Apbb3em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Lean/Body weight | homozygote | increased lean body mass | 4.82648829347454E-5 | ||
Ppp2r5e Ppp2r5eem1(IMPC)Marc |
Auditory Brain Stem Response | 30kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 4.977999196853489E-5 | ||
Dbil5 Dbil5tm1(KOMP)Wtsi |
Clinical Chemistry | Glucose | homozygote | increased circulating glucose level | 4.978841752745211E-5 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Heart Weight | Heart weight | homozygote | decreased heart weight | 4.98083682032302E-5 | ||
Herc4 Herc4tm1b(KOMP)Wtsi |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 4.9907237553270534E-5 | ||
Otud3 Otud3em1(IMPC)Marc |
Hematology | Monocyte differential count | homozygote | increased monocyte cell number | 5.0055507017532364E-5 | ||
Ufm1 Ufm1em1(IMPC)Marc |
Clinical Chemistry | Total protein | heterozygote | decreased circulating total protein level | 5.041808253736235E-5 | ||
Dlgap2 Dlgap2em1(IMPC)Mhzh |
Open Field | Whole arena average speed | homozygote | decreased locomotor activity | 5.0727412599371746E-5 | ||
Ces2e Ces2eem1(IMPC)Marc |
Hematology | Hemoglobin | homozygote | decreased hemoglobin content | 5.1877716032322496E-5 | ||
Uchl5 Uchl5tm1(NCOM)Mfgc |
Open Field | Whole arena resting time | heterozygote | decreased locomotor activity | 5.212371252127923E-5 | ||
Abhd3 Abhd3em1(IMPC)Marc |
Echo | Fractional Shortening | homozygote | decreased cardiac muscle contractility | 5.248005618341267E-5 | ||
Trim37 Trim37em1(IMPC)Marc |
Auditory Brain Stem Response | 24kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 5.293107096804306E-5 | ||
Usp30 Usp30em1(IMPC)Marc |
Auditory Brain Stem Response | 24kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 5.293107096804306E-5 | ||
Prdm2 Prdm2em1(IMPC)Marc |
Grip Strength | Forelimb and hindlimb grip strength normalised against body weight | homozygote | increased grip strength | 5.305982267600484E-5 | ||
Fbxo15 Fbxo15em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 5.310939741320908E-5 | ||
Trim37 Trim37em1(IMPC)Marc |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | homozygote | increased fasting circulating glucose level | 5.326139580574818E-5 | ||
Ppp1cc Ppp1cctm1b(EUCOMM)Wtsi |
Open Field | Whole arena resting time | homozygote | decreased locomotor activity | 5.341283031157218E-5 | ||
Cox8a Cox8aem1(IMPC)Marc |
Eye Morphology | Retina (combined) | homozygote | abnormal retina morphology | 5.370640064938925E-5 | ||
Ppp2r5d Ppp2r5dem2(IMPC)Marc |
Eye Morphology | Retina (combined) | homozygote | abnormal retina morphology | 5.370640064938925E-5 | ||
Ube2d3 Ube2d3tm1b(EUCOMM)Hmgu |
Eye Morphology | Retina (combined) | heterozygote | abnormal retina morphology | 5.370640064938925E-5 | ||
Ccdc83 Ccdc83em1(IMPC)Marc |
Eye Morphology | Retina (combined) | homozygote | abnormal retina morphology | 5.370640064938925E-5 | ||
Fbxo15 Fbxo15em1(IMPC)Marc |
Eye Morphology | Retina (combined) | homozygote | abnormal retina morphology | 5.370640064938925E-5 | ||
Prmt6 Prmt6em1(IMPC)Marc |
Eye Morphology | Retina (combined) | homozygote | abnormal retina morphology | 5.370640064938925E-5 | ||
Senp8 Senp8em1(IMPC)Marc |
Eye Morphology | Retina (combined) | heterozygote | abnormal retina morphology | 5.370640064938925E-5 | ||
Hnrnpd Hnrnpdtm1b(KOMP)Wtsi |
Open Field | Percentage center movement time | heterozygote | increased anxiety-related response | 5.393117680796422E-5 | ||
Pan2 Pan2tm1b(KOMP)Wtsi |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 5.4357878980226815E-5 | ||
Snx25 Snx25tm1b(KOMP)Wtsi |
Open Field | Periphery distance travelled | heterozygote | hyperactivity | 5.449471063911915E-5 | ||
Hilpda Hilpdaem1(IMPC)Mhzh |
Echo | LVPWs | homozygote | decreased heart left ventricle size | 5.4612301028100774E-5 | ||
Atg4b Atg4bem1(IMPC)Marc |
Clinical Chemistry | Alanine aminotransferase | homozygote | increased circulating alanine transaminase level | 5.4760766943218186E-5 | ||
Fbxo38 Fbxo38em2(IMPC)Marc |
Open Field | Whole arena average speed | homozygote | decreased locomotor activity | 5.50955519429408E-5 | ||
Prpf31 Prpf31tm1a(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | Fat mass | heterozygote | increased total body fat amount | 5.540761776501313E-5 | ||
Ube2z Ube2zem1(IMPC)Marc |
Echo | LVPWs | heterozygote | decreased heart left ventricle size | 5.562083242693916E-5 | ||
Pfkfb2 Pfkfb2tm1b(KOMP)Wtsi |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | homozygote | increased fasting circulating glucose level | 5.648602018482052E-5 | ||
Fntb Fntbtm1b(EUCOMM)Hmgu |
Hematology | Platelet count | heterozygote | thrombocytopenia | 5.70899028389249E-5 | ||
Hectd1 Hectd1tm1b(EUCOMM)Hmgu |
Clinical Chemistry | Alkaline phosphatase | heterozygote | decreased circulating alkaline phosphatase level | 5.750741183874197E-5 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Open Field | Center distance travelled | heterozygote | decreased locomotor activity | 5.814145697513595E-5 | ||
Ezh1 Ezh1tm1b(EUCOMM)Wtsi |
Acoustic Startle and Pre-pulse Inhibition (PPI) | % Pre-pulse inhibition - PPI1 | homozygote | decreased prepulse inhibition | 5.834875628352165E-5 | ||
Ctsm Ctsmtm1(KOMP)Wtsi |
Hematology | Mean cell hemoglobin concentration | homozygote | increased mean corpuscular hemoglobin concentration | 5.861412500962615E-5 | ||
Ccdc83 Ccdc83em1(IMPC)Marc |
Echo | LVAWd | homozygote | decreased heart left ventricle size | 5.908165258006193E-5 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Clinical Chemistry | Phosphorus | homozygote | decreased circulating phosphate level | 5.9515004977583885E-5 | ||
Defb43 Defb43tm1b(KOMP)Wtsi |
Echo | LVAWs | homozygote | thin ventricular wall | 6.119460886111483E-5 | ||
Prmt6 Prmt6em1(IMPC)Marc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 6.119695899542421E-5 | ||
Atg4a Atg4aem2(IMPC)Marc |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | homozygote | decreased bone mineral density | 6.12266521784477E-5 | ||
Pan2 Pan2tm1b(KOMP)Wtsi |
Heart Weight | Heart weight | homozygote | increased heart weight | 6.1304475821089E-5 | ||
Eddm3b Eddm3btm1b(KOMP)Wtsi |
Echo | LVIDd | homozygote | dilated heart left ventricle | 6.147736712591723E-5 | ||
Abhd3 Abhd3em1(IMPC)Marc |
Echo | LVIDs | homozygote | dilated heart left ventricle | 6.176074384711683E-5 | ||
Dagla Daglatm1a(EUCOMM)Wtsi |
Body Composition (DEXA lean/fat) | Body length | homozygote | decreased body length | 6.205652607604861E-5 | ||
Usp39 Usp39tm1b(EUCOMM)Hmgu |
Auditory Brain Stem Response | Click-evoked ABR threshold | heterozygote | abnormal auditory brainstem response | 6.348630267893896E-5 | ||
Abhd3 Abhd3em1(IMPC)Marc |
Echo | LVPWd | homozygote | thin ventricular wall | 6.400913844117895E-5 | ||
Usp39 Usp39tm1b(EUCOMM)Hmgu |
Combined SHIRPA and Dysmorphology | Coat - color - head | heterozygote | abnormal coat/hair pigmentation | 6.443351594498381E-5 | ||
Usp50 Usp50tm1(KOMP)Vlcg |
Acoustic Startle and Pre-pulse Inhibition (PPI) | % Pre-pulse inhibition - PPI1 | heterozygote | decreased prepulse inhibition | 6.512385152745992E-5 | ||
Fbxo10 Fbxo10tm1b(KOMP)Wtsi |
Hematology | Neutrophil cell count | homozygote | decreased neutrophil cell number | 6.517455040011555E-5 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Grip Strength | Forelimb grip strength measurement mean | homozygote | decreased grip strength | 6.529413076350465E-5 | ||
Suv39h2 Suv39h2em1(IMPC)Marc |
Clinical Chemistry | Triglycerides | homozygote | increased circulating triglyceride level | 6.649053102592006E-5 | ||
Usp40 Usp40em1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Fat/Body weight | homozygote | increased total body fat amount | 6.662985833827406E-5 | ||
Fbxo36 Fbxo36tm1b(KOMP)Wtsi |
Grip Strength | Forelimb and hindlimb grip strength measurement mean | homozygote | decreased grip strength | 6.786271114833653E-5 | ||
Fbxo28 Fbxo28em1(IMPC)Mhzh |
Open Field | Periphery permanence time | heterozygote | decreased thigmotaxis | 6.844961899332702E-5 | ||
Fbxo28 Fbxo28em1(IMPC)Mhzh |
Open Field | Center permanence time | heterozygote | decreased thigmotaxis | 6.848994235042483E-5 | ||
Fbxo28 Fbxo28em1(IMPC)Mhzh |
Open Field | Percentage center time | heterozygote | abnormal behavior | 6.850584759376943E-5 | ||
Rabggta Rabggtatm1.1(KOMP)Vlcg |
Hematology | Neutrophil differential count | heterozygote | decreased neutrophil cell number | 6.855247920611873E-5 | ||
Usp15 Usp15em1(IMPC)Marc |
Open Field | Periphery distance travelled | homozygote | decreased locomotor activity | 6.857412518002093E-5 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Open Field | Center permanence time | heterozygote | increased thigmotaxis | 6.926050991751254E-5 | ||
Ppp2r5e Ppp2r5eem1(IMPC)Marc |
Auditory Brain Stem Response | 24kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 6.931604002602398E-5 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Open Field | Percentage center time | heterozygote | abnormal behavior | 6.965632201172411E-5 | ||
Cdc42ep5 Cdc42ep5tm1(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Lean mass | homozygote | decreased lean body mass | 7.03242258168757E-5 | ||
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
Open Field | Periphery permanence time | heterozygote | increased thigmotaxis | 7.040241325739771E-5 | ||
Bbof1 Bbof1em1(IMPC)Marc |
Clinical Chemistry | Iron | homozygote | increased circulating iron level | 7.050466228974983E-5 | ||
Herc6 Herc6tm1b(EUCOMM)Hmgu |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 7.069652929203585E-5 | ||
Ints6l Ints6lem1(IMPC)Marc |
Clinical Chemistry | Phosphorus | hemizygote | decreased circulating phosphate level | 7.087488484103233E-5 | ||
Bbc3 Bbc3em1(IMPC)Marc |
Open Field | Periphery average speed | homozygote | hyperactivity | 7.105866097845137E-5 | ||
B3galt1 B3galt1em1(IMPC)Marc |
Open Field | Center distance travelled | homozygote | decreased locomotor activity | 7.15754649718292E-5 | ||
Usp32 Usp32em1(IMPC)Mhzh |
Hematology | Red blood cell distribution width | heterozygote | increased red blood cell distribution width | 7.278953125933185E-5 | ||
B3galt1 B3galt1em1(IMPC)Marc |
Open Field | Whole arena resting time | homozygote | decreased locomotor activity | 7.45968718547374E-5 | ||
Fbxo38 Fbxo38em2(IMPC)Marc |
Open Field | Center resting time | homozygote | decreased locomotor activity | 7.463515066774562E-5 | ||
Ctsm Ctsmtm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Locomotor activity | homozygote | decreased exploration in new environment | 7.653204374946654E-5 | ||
Ube2d3 Ube2d3tm1b(EUCOMM)Hmgu |
Open Field | Periphery average speed | heterozygote | decreased locomotor activity | 7.679561531404033E-5 | ||
Ppp2r5e Ppp2r5eem1(IMPC)Marc |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | decreased bone mineral content | 7.701354479650036E-5 | ||
Ube2d3 Ube2d3tm1b(EUCOMM)Hmgu |
Open Field | Distance travelled - total | heterozygote | decreased locomotor activity | 7.76115120970644E-5 | ||
Fbxw8 Fbxw8tm1b(EUCOMM)Hmgu |
Clinical Chemistry | Creatinine | heterozygote | increased circulating creatinine level | 7.792857650201768E-5 | ||
Prdm2 Prdm2em1(IMPC)Marc |
Hematology | Hematocrit | homozygote | decreased hematocrit | 7.883607759140432E-5 | ||
Vav2 Vav2em1(IMPC)Marc |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 7.900413766037673E-5 | ||
Usp46 Usp46em1(IMPC)Marc |
Hematology | Mean cell volume | homozygote | increased mean corpuscular volume | 7.908334373496473E-5 | ||
Ppp2r2a Ppp2r2atm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Lean/Body weight | heterozygote | decreased lean body mass | 7.939890929264948E-5 | ||
Ppp2r5e Ppp2r5eem1(IMPC)Marc |
Open Field | Distance travelled - total | homozygote | decreased locomotor activity | 7.982641545822844E-5 | ||
Usp43 Usp43em1(IMPC)Marc |
Grip Strength | Forelimb grip strength measurement mean | homozygote | decreased grip strength | 7.994537736522034E-5 | ||
Ankle1 Ankle1tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Coat - color - back | homozygote | abnormal coat/hair pigmentation | 8.028338197618723E-5 | ||
Dusp7 Dusp7tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Coat - color - back | homozygote | abnormal coat/hair pigmentation | 8.028338197618723E-5 | ||
Alg1 Alg1tm1b(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Coat - color - back | heterozygote | abnormal coat/hair pigmentation | 8.028338197618723E-5 | ||
Fbxo38 Fbxo38em2(IMPC)Marc |
Open Field | Periphery average speed | homozygote | decreased locomotor activity | 8.0881203757599E-5 | ||
Usp15 Usp15em1(IMPC)Marc |
Open Field | Center average speed | homozygote | decreased locomotor activity | 8.124014129862189E-5 | ||
Fbxo22 Fbxo22tm1b(EUCOMM)Wtsi |
Echo | LVAWd | heterozygote | decreased heart left ventricle size | 8.130952483043075E-5 | ||
Emc4 Emc4tm1(KOMP)Wtsi |
Echo | LVPWs | heterozygote | decreased heart left ventricle size | 8.240524039138108E-5 | ||
Atg4b Atg4bem1(IMPC)Marc |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | homozygote | increased fasting circulating glucose level | 8.244205673690885E-5 | ||
Lhcgr Lhcgrtm1(KOMP)Vlcg |
Hematology | Mean cell volume | homozygote | decreased mean corpuscular volume | 8.270744001492858E-5 | ||
Usp32 Usp32em1(IMPC)Mhzh |
Clinical Chemistry | Albumin | heterozygote | decreased circulating serum albumin level | 8.325672388309613E-5 | ||
Ash1l Ash1ltm2b(EUCOMM)Hmgu |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | heterozygote | increased fasting circulating glucose level | 8.349513518624008E-5 | ||
Atg4d Atg4dem1(IMPC)Marc |
Open Field | Percentage center time | homozygote | abnormal behavior | 8.364333189092577E-5 | ||
Atg4d Atg4dem1(IMPC)Marc |
Open Field | Center permanence time | homozygote | increased thigmotaxis | 8.364906534552574E-5 | ||
Herc6 Herc6tm1b(EUCOMM)Hmgu |
Hematology | Platelet count | homozygote | thrombocytopenia | 8.36835679365322E-5 | ||
Atg4d Atg4dem1(IMPC)Marc |
Open Field | Periphery permanence time | homozygote | increased thigmotaxis | 8.391038863919675E-5 | ||
Otud3 Otud3em1(IMPC)Marc |
Hematology | Monocyte cell count | homozygote | increased monocyte cell number | 8.391579467570409E-5 | ||
Ezh1 Ezh1tm1b(EUCOMM)Wtsi |
Hematology | Red blood cell distribution width | homozygote | decreased red blood cell distribution width | 8.399007492698729E-5 | ||
Ezh1 Ezh1tm1b(EUCOMM)Wtsi |
Acoustic Startle and Pre-pulse Inhibition (PPI) | % Pre-pulse inhibition - PPI3 | homozygote | decreased prepulse inhibition | 8.400752994930372E-5 | ||
Hnrnpd Hnrnpdtm1b(KOMP)Wtsi |
Open Field | Number of center entries | heterozygote | decreased locomotor activity | 8.423720282735303E-5 | ||
Fbxo10 Fbxo10tm1b(KOMP)Wtsi |
Clinical Chemistry | Glucose | homozygote | decreased circulating glucose level | 8.436518692178652E-5 | ||
Usp39 Usp39tm1b(EUCOMM)Hmgu |
Combined SHIRPA and Dysmorphology | Coat - color - abdomen | heterozygote | abnormal coat/hair pigmentation | 8.441014506388456E-5 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Body Composition (DEXA lean/fat) | Fat mass | homozygote | increased total body fat amount | 8.47115006763488E-5 | ||
Hectd3 Hectd3tm1(NCOM)Cmhd |
Echo | Fractional Shortening | homozygote | increased cardiac muscle contractility | 8.531017374480143E-5 | ||
Zswim1 Zswim1tm1b(KOMP)Mbp |
Hematology | Mean cell hemoglobin concentration | homozygote | increased mean corpuscular hemoglobin concentration | 8.538776455679908E-5 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Clinical Chemistry | Alkaline phosphatase | homozygote | increased circulating alkaline phosphatase level | 8.677248115418479E-5 | ||
Fbxl15 Fbxl15em1(IMPC)Marc |
Auditory Brain Stem Response | 24kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 8.745133527554572E-5 | ||
Oxsm Oxsmem2(IMPC)Marc |
Auditory Brain Stem Response | 24kHz-evoked ABR Threshold | heterozygote | abnormal auditory brainstem response | 8.745133527554572E-5 | ||
Bod1 Bod1tm1b(KOMP)Wtsi |
Auditory Brain Stem Response | 24kHz-evoked ABR Threshold | heterozygote | abnormal auditory brainstem response | 8.745133527554572E-5 | ||
Defb43 Defb43tm1b(KOMP)Wtsi |
Auditory Brain Stem Response | 24kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 8.745133527554572E-5 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Auditory Brain Stem Response | 24kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 8.745133527554572E-5 | ||
Dctd Dctdem1(IMPC)Marc |
Auditory Brain Stem Response | 24kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 8.745133527554572E-5 | ||
Fbxl8 Fbxl8em2(IMPC)Marc |
Auditory Brain Stem Response | 24kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 8.745133527554572E-5 | ||
Bap1 Bap1em2(IMPC)Marc |
Auditory Brain Stem Response | 24kHz-evoked ABR Threshold | heterozygote | abnormal auditory brainstem response | 8.745133527554572E-5 | ||
Atg4b Atg4bem1(IMPC)Marc |
Auditory Brain Stem Response | 24kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 8.745133527554572E-5 | ||
Ube2w Ube2wtm1b(EUCOMM)Wtsi |
Auditory Brain Stem Response | 24kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 8.745133527554572E-5 | ||
Fbxo24 Fbxo24em2(IMPC)Marc |
Auditory Brain Stem Response | 24kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 8.745133527554572E-5 | ||
Usp43 Usp43em1(IMPC)Marc |
Auditory Brain Stem Response | 24kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 8.745133527554572E-5 | ||
Ppp1r14a Ppp1r14aem1(IMPC)Marc |
Auditory Brain Stem Response | 24kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 8.745133527554572E-5 | ||
Akr1c12 Akr1c12tm1b(KOMP)Wtsi |
Auditory Brain Stem Response | 24kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 8.745133527554572E-5 | ||
Cimip2b Cimip2btm1(KOMP)Wtsi |
Auditory Brain Stem Response | 24kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 8.745133527554572E-5 | ||
Hectd1 Hectd1tm1b(EUCOMM)Hmgu |
Combined SHIRPA and Dysmorphology | Coat - color pattern - abdomen | heterozygote | abnormal coat/hair pigmentation | 8.758101466810331E-5 | ||
Mir320 Mir320tm1Wtsi |
Combined SHIRPA and Dysmorphology | Tail - thickness | heterozygote | abnormal tail morphology | 8.758101466810331E-5 | ||
Phf5a Phf5aem2(IMPC)Marc |
Hematology | Red blood cell distribution width | heterozygote | increased red blood cell distribution width | 8.85900590219535E-5 | ||
Kdm2b Kdm2bem1(IMPC)Marc |
Clinical Chemistry | Glucose | heterozygote | decreased circulating glucose level | 8.875932689988986E-5 | ||
B3galt1 B3galt1em1(IMPC)Marc |
Open Field | Latency to center entry | homozygote | decreased exploration in new environment | 8.966147288447246E-5 | ||
Fbxl5 Fbxl5em1(IMPC)Marc |
Clinical Chemistry | Aspartate aminotransferase | heterozygote | decreased circulating aspartate transaminase level | 8.983619773061946E-5 | ||
Bcl2l13 Bcl2l13em1(IMPC)Marc |
Hematology | Lymphocyte cell count | homozygote | decreased lymphocyte cell number | 9.020359721034765E-5 | ||
Ppp2r5e Ppp2r5eem1(IMPC)Marc |
Open Field | Center average speed | homozygote | decreased locomotor activity | 9.14947668206878E-5 | ||
Alg1 Alg1tm1b(KOMP)Wtsi |
Hematology | White blood cell count | heterozygote | increased leukocyte cell number | 9.162191417999566E-5 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Clinical Chemistry | Total cholesterol | homozygote | increased circulating cholesterol level | 9.172682621283457E-5 | ||
Fbxo2 Fbxo2tm1b(EUCOMM)Wtsi |
Open Field | Periphery resting time | homozygote | decreased locomotor activity | 9.182915528072044E-5 | ||
Mir320 Mir320tm1Wtsi |
Combined SHIRPA and Dysmorphology | Tail - length | heterozygote | abnormal tail length | 9.197309555020183E-5 | ||
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
Open Field | Whole arena average speed | homozygote | decreased locomotor activity | 9.284444968216121E-5 | ||
Usp32 Usp32em1(IMPC)Mhzh |
Hematology | White blood cell count | heterozygote | increased leukocyte cell number | 9.297134238295257E-5 | ||
Ube2z Ube2zem1(IMPC)Marc |
Hematology | Mean platelet volume | heterozygote | increased mean platelet volume | 9.301445970777422E-5 | ||
Mast1 Mast1em1(IMPC)Marc |
Heart Weight | Heart weight | homozygote | decreased heart weight | 9.391219646204263E-5 | ||
Fshr Fshrtm1(KOMP)Vlcg |
Combined SHIRPA and Dysmorphology | Startle response | homozygote | abnormal startle reflex | 9.454732207814232E-5 | ||
Phf3 Phf3em2(IMPC)Marc |
Combined SHIRPA and Dysmorphology | Startle response | homozygote | abnormal startle reflex | 9.454732207814232E-5 | ||
Hilpda Hilpdaem1(IMPC)Mhzh |
Echo | Fractional Shortening | homozygote | decreased cardiac muscle contractility | 9.529420640319586E-5 | ||
Trim37 Trim37em1(IMPC)Marc |
Grip Strength | Forelimb and hindlimb grip strength measurement mean | homozygote | increased grip strength | 9.538838639855385E-5 | ||
Abhd3 Abhd3em1(IMPC)Marc |
Open Field | Center resting time | homozygote | decreased locomotor activity | 9.600157500244677E-5 | ||
Mir350 Mir350tm1Wtsi |
Echo | LVIDs | homozygote | abnormal heart left ventricle morphology | 9.613747533876449E-5 | ||
Ints6l Ints6lem1(IMPC)Marc |
Clinical Chemistry | Triglycerides | hemizygote | increased circulating triglyceride level | 9.653640881879255E-5 | ||
Zfp36 Zfp36tm1(KOMP)Vlcg |
Hematology | White blood cell count | heterozygote | increased leukocyte cell number | 9.686242265161127E-5 | ||
Fbxo2 Fbxo2tm1b(EUCOMM)Wtsi |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | homozygote | decreased fasting circulating glucose level | 9.773481724550948E-5 | ||
Ppp2r5e Ppp2r5eem1(IMPC)Marc |
Hematology | Mean platelet volume | homozygote | decreased mean platelet volume | 9.783279529074207E-5 | ||
Ppp2r1b Ppp2r1btm1b(EUCOMM)Wtsi |
Combined SHIRPA and Dysmorphology | Lower teeth appearance | homozygote | abnormal tooth morphology | 9.847206092672423E-5 | ||
Ap5z1 Ap5z1tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Head morphology | homozygote | abnormal head morphology | 9.847206092672423E-5 | ||
Phf21b Phf21bem1(IMPC)Marc |
Hematology | Basophil differential count | homozygote | increased basophil cell number | 9.912026871461421E-5 | ||
Ezh1 Ezh1tm1b(EUCOMM)Wtsi |
Acoustic Startle and Pre-pulse Inhibition (PPI) | % Pre-pulse inhibition - PPI2 | homozygote | decreased prepulse inhibition | 9.920941374730319E-5 | ||
Atg4c Atg4cem2(IMPC)Marc |
Body Composition (DEXA lean/fat) | Bone Area | homozygote | abnormal bone structure | 9.93548528640531E-5 | ||
Cox8a Cox8aem1(IMPC)Marc |
Grip Strength | Forelimb grip strength normalised against body weight | homozygote | decreased grip strength | 9.962953481590375E-5 |